Investigating Detergent and Lipid Systems for the Study of Membrane Protein Interactions: Characterizing Caveolin Oligomerization by Rieth, Monica D
Lehigh University
Lehigh Preserve
Theses and Dissertations
2014
Investigating Detergent and Lipid Systems for the
Study of Membrane Protein Interactions:
Characterizing Caveolin Oligomerization
Monica D. Rieth
Lehigh University
Follow this and additional works at: http://preserve.lehigh.edu/etd
Part of the Chemistry Commons
This Dissertation is brought to you for free and open access by Lehigh Preserve. It has been accepted for inclusion in Theses and Dissertations by an
authorized administrator of Lehigh Preserve. For more information, please contact preserve@lehigh.edu.
Recommended Citation
Rieth, Monica D., "Investigating Detergent and Lipid Systems for the Study of Membrane Protein Interactions: Characterizing
Caveolin Oligomerization" (2014). Theses and Dissertations. Paper 1605.
i 
 
 
 
 
Investigating Detergent and Lipid Systems for the Study of Membrane Protein 
Interactions: Characterizing Caveolin Oligomerization 
 
 
 
by 
 
 
Monica D. Rieth 
 
 
 
 
 
 
A Dissertation 
 
Presented to the Graduate and Research Committee 
 
of Lehigh University 
 
in Candidacy for the Degree of 
 
Doctor of Philosophy 
 
 
 
 
 
 
in 
 
Chemistry 
 
 
 
 
 
Lehigh University 
 
January 12, 2014 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 Copyright 
Monica D. Rieth 
iii 
 
 
 
 
 Approved and recommended for acceptance as a dissertation in partial fulfillment of 
the requirements for the degree of Doctor of Philosophy 
 
Monica D. Rieth 
Investigating Detergent and Lipid Systems for the Study of Membrane Protein 
Interactions: Characterizing caveolin oligomerization 
 
 
 
 
                                                 
Defense Date 
 
                                                                     
        Dissertation Director 
        Kerney Jebrell Glover 
                                                                                                 
Approved Date    
                                                                  
     
                                                                     
 
        Committee Members: 
 
 
 
                                                        
        Robert Flowers, II 
 
 
                                                                      
        Dmitri Vezenov 
 
 
                                                                      
        Julia Koeppe 
 
 
               
 
      
iv 
 
ACKNOWLEDGMENTS 
 
This dissertation represents the culmination of hard work and dedication for 
which I cannot take full credit.  I would like to first acknowledge and thank my advisor, 
Professor Kerney Jebrell Glover, for his advice and support in this work.  I also want to 
thank him for always encouraging me to explore challenging research questions and 
offering creative solutions to address them.  I would like to thank my thesis committee: 
Professor Robert Flowers, II, Professor Dmitri Vesenov, and Professor Julia Koeppe for 
their scientific insights and helpful suggestions.  I would like to thank my fellow group 
members: Dr. Jinwoo Lee, Kyle Root, and Sarah Plucinsky for their helpful advice and 
on-going support.  Their suggestions have been very valuable to my research.  I would 
also like to thank Professor Steve Mylon at Lafayette College for his help in carrying out 
the dynamic light scattering experiments, and Michael Kelly for his contribution to the 
OmpX project.  Lastly, I especially want to thank my family and friends for their 
unconditional love and support.        
 v 
TABLE OF CONTENTS 
 
List of Figures………………………………………………………………………………....xii 
 
List of Appendices………………………………………………………………………….....xv 
 
List of Tables………………………………………………………………………………....xvi 
 
List of Abbreviations………………………………………………………………………...xvii 
 
Abstract ....................................................................................................................................... 1 
  
 
Chapter 1. Membrane Protein Biochemistry 
  
 Introduction ........................................................................................................................... 3 
 
 Membrane Proteins ............................................................................................................... 3 
 
 Schematic Diagram of Membrane Protein Classes (Figure 1-1) .......................................... 4 
 
 Detergents and Lipids ........................................................................................................... 5   
 
 Diagram of a Micelle and Bicelle (Figure 1-2) ..................................................................... 7 
 
 Caveolae and Caveolin ......................................................................................................... 9 
  
 Sequence Alignment of Caveolin 1, 2, 3 (Figure 1-3) ........................................................ 10 
 
 Caveolin and Disease .......................................................................................................... 11 
 
 Caveolin Structure .............................................................................................................. 14 
  
 Diagram of proposed regions of caveolin-1 (Figure 1-4) ................................................... 14 
 
 Caveolin Oligomerization ................................................................................................... 17 
 
 Proposed mechanism of caveolae curvature (Figure 1-5) ................................................... 16 
 
 Introduction to Analytical Ultracentrifugation ................................................................... 19 
 
References for Introduction ................................................................................................ 23 
 vi 
 
Chapter 2.  Analysis of Caveolin-1 Oligomerization in DPC Micelles 
 
 Abstract ............................................................................................................................... 29 
 
 Introduction ......................................................................................................................... 30 
 
 Materials and Methods........................................................................................................ 34 
 
 Protein Expression and Purification ................................................................................... 34 
 
 Gel Filtration Chromatography ........................................................................................... 34 
 
 Analytical Ultracentrifugation ............................................................................................ 35 
 
 Results and Discussion ....................................................................................................... 36 
 
 Conclusions ......................................................................................................................... 42 
 
 Figures for Chapter 2 .......................................................................................................... 43 
 
Gel filtration chromatograms of WT and P132L (Figure 2-1) ..................................... 43 
 
 Sedimentation equilibrium profiles of WT and P132L (Figure 2-2) ............................ 44 
 
 Gel filtration chromatograms of truncated caveolin-1 constructs (Figure 2-3) ............ 45 
 
 
1H-15N TROSY HSQC spectrum of Cav1(96-136)_P132L (Figure 2-4) ..................... 46 
 
 Overlaid HSQC spectra of WT Cav1(96-136) and P132L (Figure 2-5) ...................... 47 
 
 Chemical shift analysis of WT Cav1(96-136) and P132L (Figure 2-6) ....................... 48 
 
  Gel filtration chromatograms of WT Cav1 with P132X mutants (Figure 2-7) ............ 49 
 
 Schematic diagram of WT Cav1 and P132L mutant dimer (Figure 2-8) ..................... 50 
 
 References for Chapter 2 .................................................................................................... 51 
 
 
 
Chaper 3.  Evaluating Caveolin-1 Oligomerization in a Bilayer 
 
 Abstract ............................................................................................................................... 55 
 
 Introduction ......................................................................................................................... 56 
 
 Materials and Methods........................................................................................................ 58 
 
 vii 
 Density Matching Bicelles ........................................................................................... 58 
 
 Incorporation of Caveolin-1(62-178) in Bicelles ......................................................... 61 
 
 Results and Discussion ....................................................................................................... 61 
 
 Choice of Caveolin-1 Construct ................................................................................... 61 
 
 Density Matching Experiments .................................................................................... 62 
 
 Caveolin-1 Incorporation into Bicelles ........................................................................ 63  
 
 Caveolin-1 Oligomerization in Bicelles ....................................................................... 64 
  
Conclusions ......................................................................................................................... 65 
 
Data for Chapter 3 .............................................................................................................. 66 
 
Density measurements of bicelle solutions (Table 3.1) ............................................... 66 
 
Partial Specific Volumes of q = 1.0 bicelles (Table 3.2) ............................................. 67 
 
Density matching results for q = 1.0 bicelles in D2O (Figure 3-1) ............................... 68 
 
Density matching results for q = 1.0 bicelles in glycerol (Figure 3-2) ......................... 69 
 
Density matching results for q = 1.0 bicelles in sucrose (Figure 3-3) .......................... 70 
 
Meff  plots of bicelles in D2O, glycerol, and sucrose (Figure 3-4) ................................. 71 
 
Sedimentation equilibrium results of caveolin-1 in bicelles (Figure 3-5) .................... 72 
 
 Chapter 3 References .......................................................................................................... 73 
 
 
 
Chapter 4.  Investigating LMPG and LMPC micelles for the study of membrane protein 
interactions in the AUC 
  
 Abstract ............................................................................................................................... 74 
 
 Introduction ......................................................................................................................... 75 
 
 Materials and Methods........................................................................................................ 77 
 
 Measuring the density of LMPG and LMPC lipid solutions ........................................ 77 
 
 Preparation of LMPG sample for analytical ultracentrifugation .................................. 77 
 
 viii 
 Preparation of caveolin-1(96-136) NMR samples in LMPG / LMPC lipid mixtures .. 78 
 Results and Discussion ....................................................................................................... 79 
 Conclusions ......................................................................................................................... 83 
 Data for Chapter 4 .............................................................................................................. 84 
 Density Measurements of LMPG solutions (Table 4.1) ............................................... 84 
 Density Measurements of LMPC solutions (Table 4.2) ............................................... 85 
 Density of LMPG micelles (Figure 4-1) ...................................................................... 86 
 Meff determination of LMPG micelles (Figure 4-2) ...................................................... 87 
 Density of LMPC micelles (Figure 4-3)....................................................................... 88 
 Density measurements of LMPG-LMPC mixtures (Table 4.3) ................................... 89 
 Density measurements of 50-50 LMPG-LMPC solutions (Figure 4-4) ....................... 90 
 
15N-1H HSQC spectrum of Cav1(96-136) in 100 mM LMPG (Figure 4-5) ................. 91  
 
15N-1H HSQC spectrum of Cav1(96-136) in  
75 mM / 25 mM LMPG / LMPC (Figure 4-6) ............................................................. 92 
 
15N-1H HSQC spectrum of Cav1(96-136) in  
50 mM / 50 mM LMPG / LMPC (Figure 4-7) ............................................................. 93 
 
15N-1H HSQC spectrum of Cav1(96-136) in  
25 mM LMPG / 75 mM LMPC (Figure 4-8) ............................................................... 94 
 
15N-1H HSQC spectrum of Cav1(96-136) in 100 mM LMPC (Figure 4-9) ................. 95 
 
Chapter 4 References .......................................................................................................... 96 
 
 
 
 
Chapter 5. Investigation of C8E5 / DMPC Aggregates 
 
 Abstract ............................................................................................................................... 97 
 
 Introduction ......................................................................................................................... 98 
 
 Materials and Methods...................................................................................................... 101 
 
 
31P-Phosphorus NMR Experiments ............................................................................ 101 
 ix 
 Dynamic Light Scattering Experiments ..................................................................... 101 
  
 Sedimentation Equilibrium (AUC) ............................................................................ 103 
 
 Results and Discussion ..................................................................................................... 104 
 
 Conclusions ....................................................................................................................... 106 
 
 Data for Chapter 5 ............................................................................................................ 107 
 
 Viscosity measurements of C8E5 / DMPC samples (Table 5.1) ................................ 107 
 
 Viscosity measurements of C8E5 / DMPC samples (Table 5.2) ................................ 108 
 
  1-D 31P-phosphorus NMR spectrum of DMPC / DHPC  
bicelles and DMPC / C8E5 aggregates at 25 °C (Figure 5-1) .................................... 109 
 
1-D 31P-phosphorus NMR spectrum of DMPC / DHPC  
bicelles and DMPC / C8E5 aggregates at 37 °C (Figure 5-2) .................................... 110 
 
Hydrodynamic radius determination of DMPC / C8E5 samples at  
different q values (Figure 5-3) ................................................................................... 111 
 
Hydrodynamic radius determination of DMPC / C8E5 aggregates at  
various lipid concentrations (Figure 5-4) ................................................................... 112 
 
Sedimentation equilibrium data of DMPC / C8E5 lipid aggregate at  
various q values (Figure 5-5) ..................................................................................... 113 
 
 References for Chapter 5 .................................................................................................. 114 
 
 
 
Chapter 6. Expression and Purification of Membrane Proteins 
 
 Abstract ............................................................................................................................. 115 
 
 Introduction ....................................................................................................................... 116 
 
 Materials and Methods...................................................................................................... 118 
 
 WALP, Cav1(62-178), Cav1(62-178) truncated and point mutants .......................... 118 
 
 OmpX ......................................................................................................................... 127 
 
 Phosphatidylethanolamine methyltransferase (PmtA) ............................................... 128 
 
 Results and Discussion ..................................................................................................... 134 
 
 x 
 WALP ........................................................................................................................ 134 
 
 OmpX ......................................................................................................................... 136 
 
 Cav1(62-178) and Cav1(62-178) mutants .................................................................. 137 
 
 PmtA .......................................................................................................................... 138 
 
 Conclusions ....................................................................................................................... 139 
 
 Data and Figures for Chapter 6 ......................................................................................... 140 
 
  Schematic diagram of pET-24a vector and construct design (Figure 6-1) ................. 140 
 
 Proposed mechanism of cyanogen bromide reaction (Figure 6-2) ............................. 141 
 
 Test expression of TrpLE-Ubiquitin-WALP (Figure 6-3) ......................................... 142 
 
 HPLC purification of TrpLE-Ubiquitin-WALP (Figure 6-4) .................................... 143 
 
 MALDI-TOF spectrum of WALP (Figure 6-5) ......................................................... 144 
 
 SDS-PAGE inclusion body preparation of OmpX (Figure 6-6) ................................ 145 
 
 SDS-PAGE of OmpX nickel column purification (Figure 6-7) ................................. 146 
 
 Growth profile of E. coli in auto-induction media (Figure 6-8) ................................. 147 
 
 SDS-PAGE of truncated Cav1(62-178) mutants (Figure 6-9) ................................... 148 
 
 HPLC purification of Cav1(62-178)_WT and mutants (Figure 6-10) ....................... 149 
 
 MALDI-TOF spectrum of Cav1(62-178)_WT (Figure 6-11) .................................... 150 
 
 SDS-PAGE of PmtA test expression (Figure 6-12) ................................................... 151 
 
  SDS-PAGE of inclusion body prep. and nickel purification  
of PmtA (Figure 6-13) ................................................................................................ 152 
  
 SDS-PAGE evaluation of PmtA purity (Figure 14) ................................................... 153 
 
 References for Chapter 6 .................................................................................................. 154 
 
 
 
Appendix I.  Common Lab Procedures and Protocols .............................................................. 156 
 
 Preparing and Running a DNA Agarose Gel .................................................................... 159 
  
 xi 
Purification of Digested DNA using Qiagen Gel Extraction kit ....................................... 157 
 
Transformation into Competent E. coli cells .................................................................... 158 
 
 Preparation of E. coli Glycerol Stocks for Growths ......................................................... 159 
 
 Procedure for DNA Test Digest ........................................................................................ 159 
 
 Procedure for Protein Test Expression ............................................................................. 160 
 
 Preparation of SDS-PAGE Gels ....................................................................................... 161 
 
 
 
Appendix II.  Buffers, Growth Media, and Solutions ............................................................. 163 
 
 5X Nucleic Acid Loading buffer ...................................................................................... 163 
 
 5X Tris-acetate EDTA buffer ........................................................................................... 163 
 
 1X Western Blot Transfer buffer ...................................................................................... 163 
 
 10X TBS buffer ................................................................................................................ 163 
 
 1X TBST buffer ................................................................................................................ 163 
 
 5X SDS Loading buffer (Reducing) ................................................................................. 163 
  
 10X Electrophoresis buffer ............................................................................................... 164 
 
Acrylamide Gel and Stacking buffers ............................................................................... 164 
 
 Coomassie Blue Staining / Destaining solution ................................................................ 164 
 
 ZYM-5052 Auto-inducing media ..................................................................................... 164 
 
 N-5052 Auto-inducing media ........................................................................................... 165 
 
 MDG (MDAG) starter culture growth media ................................................................... 165 
 
 
Vita .......................................................................................................................................... 166 
 
 
 
  
  
 xii 
 
LIST OF FIGURES 
 
 
Chapter 1 
 
Figure 1-1 Schematic Diagram of Membrane Protein Classes .............................. 4 
  
Figure 1-2 Diagram of a Micelle and Bicelle ........................................................ 7 
  
Figure 1-3 Sequence Alignment of Caveolin 1, 2, 3 ............................................ 10 
  
Figure 1-4 Diagram of proposed regions of caveolin-1 ....................................... 14 
  
Figure 1-5 Proposed mechanism of caveolae curvature ...................................... 16 
 
 
Chapter 2 
 
Figure 2-1 Gel filtration chromatograms of WT and P132L ............................... 43 
 
Figure 2-2 Sedimentation equilibrium profiles of WT and P132L ...................... 44 
 
Figure 2-3 Gel filtration chromatograms of truncated caveolin-1 constructs ...... 45 
 
Figure 2-4 1H-15N TROSY HSQC spectrum of Cav1(96-136)_P132L ............... 46 
 
Figure 2-5  Overlay of HSQC spectra of WT Cav1(96-136) and P132L ............. 47 
 
Figure 2-6 Chemical shift analysis of WT Cav1(96-136) and P132L ................. 48 
 
Figure 2-7 Gel filtration chromatograms of WT Cav1 with P132X mutants....... 49 
 
Figure 2-8 Schematic diagram of WT Cav1 and P132L mutant dimer ............... 50 
 
 
Chapter 3 
 
Figure 3-1 Density matching results for q = 1.0 bicelles in D2O ......................... 68 
 
Figure 3-2 Density matching results for q = 1.0 bicelles in glycerol ................... 69 
 
Figure 3-3 Density matching results for q = 1.0 bicelles in sucrose .................... 70 
 
Figure 3-4 Meff plots of bicelles in D2O, glycerol, and sucrose ............................ 71 
 
Figure 3-5 Sedimentation equilibrium results of caveolin-1 in bicelles .............. 72 
  
 xiii 
 
 
Chapter 4 
  
Figure 4-1 Density of LMPG micelles ................................................................. 86 
  
Figure 4-2 Meff determination of LMPG micelles ................................................ 87 
  
Figure 4-3 Density of LMPC micelles ................................................................. 88 
  
Figure 4-4 Density measurements of 50-50 LMPG-LMPC solutions ................. 90 
  
Figure 4-5 15N-1H HSQC spectrum of Cav1(96-136) in 100 mM LMPG ........... 91 
  
Figure 4-6 15N-1H HSQC spectrum of Cav1(96-136) in  
75 mM LMPG / 25 mM LMPC  ........................................................ 92 
  
 Figure 4-7 15N-1H HSQC spectrum of Cav1(96-136) in 
 50 mM LMPG / 50 mM LMPC ......................................................... 93 
  
 Figure 4-8 15N-1H HSQC spectrum of Cav1(96-136) in 
 25 mM LMPG / 75 mM LMPC ......................................................... 94 
 
Figure 4-9 15N-1H HSQC spectrum Cav1(96-136) in 100 mM LMPC ................ 95 
 
  
Chapter 5 
 
Figure 5-1 1-D 31P-phosphorus NMR spectrum of DMPC / DHPC  
bicelles and DMPC / C8E5 aggregates at 25 °C .............................. 109 
 
 Figure 5-2 1-D 31P-phosphorus NMR spectrum of DMPC / DHPC  
 bicelles and DMPC / C8E5 aggregates at 37 °C .............................. 110 
 
 Figure 5-3 Hydrodynamic radius determination of DMPC / C8E5  
samples at different q values ............................................................ 111 
 
 Figure 5-4 Hydrodynamic radius determination of DMPC / C8E5  
samples at various lipid concentrations ............................................ 112 
 
 Figure 5-5 Sedimentation equilibrium data of DMPC / C8E5 lipid aggregate at 
 various q values ................................................................................ 113 
 
 
Chapter 6 
 
Figure 6-1 Schematic diagram of pET-24a vector and construct design ........... 140 
 
 Figure 6-2 Proposed cyanogen bromide reaction mechanism ........................... 141 
 xiv 
  
 Figure 6-3 SDS-PAGE test expression of TrpLE-Ubiquitin-WALP ................. 142 
 
 Figure 6-4 HPLC purification of TrpLE-Ubiquitin-WALP ............................... 143 
 
 Figure 6-5 MALDI-TOF spectrum of WALP.................................................... 144 
 
 Figure 6-6 SDS-PAGE inclusion body preparation of OmpX ........................... 145 
 
 Figure 6-7 SDS-PAGE of OmpX nickel column purification ........................... 146 
 
 Figure 6-8 Growth profile of E. coli in auto-induction media ........................... 147 
 
 Figure 6-9 SDS-PAGE of truncated Cav1(62-178) mutants.............................. 148 
 
 Figure 6-10 HPLC purification of Cav1(62-178) _WT and mutants ................... 149 
 
 Figure 6-11 MALDI-TOF spectrum of Cav1(62-178)_WT ................................ 150 
 
 Figure 6-12 SDS-PAGE of PmtA test expression ............................................... 151 
 
 Figure 6-13 SDS-PAGE of inclusion body prep.  
and nickel purification of PmtA ....................................................... 152 
 
 Figure 6-14 SDS-PAGE evaluation of PmtA purity ............................................ 153 
 
 xv 
 
LIST OF APPENDICES 
 
Appendix I.  Common Lab Procedures and Protocols ............................................... 156 
 
Appendix II.  Buffers, Growth Media and Solutions ................................................. 163
 xvi 
LIST OF TABLES 
 
Chapter 3 
 
 Table 3.1 Density measurements of bicelle solutions ............................................... 66 
  
Table 3.2 Partial Specific Volumes of q = 1.0 bicelles ............................................. 67 
 
 
Chapter 4 
  
Table 4.1 Density measurements of LMPG solutions .............................................. 84 
  
Table 4.2 Density measurements of LMPC solutions .............................................. 85 
  
Table 4.3 Density measurements of LMPG-LMPC mixtures .................................. 89 
 
 
Chapter 5 
  
Table 5.1 Viscosity measurements of C8E5 / DMPC samples ............................... 107 
  
Table 5.2 Viscosity measurements of C8E5 / DMPC samples ............................... 108 
 
 
  
 xvii 
 
LIST OF ABBREVIATIONS 
 
DPC:  Dodecylphosphocholine 
LMPG:  lyso-Myristoylphosphatidylglycerol 
LMPC:  lyso-Myristoylphosphatidylcholine 
PFOA:  Pentafluorooctanoic acid 
HFIP:  Hexafluoroisopropanol 
AUC:  Analytical Ultracentrifugation 
SE: Sedimentation Equilibrium 
HPLC:  High Performance Liquid Chromatography 
MALDI-TOF:  Matrix-Assisted Laser Desorption/Ionization time-of-flight  
DHPC:  Dihexanoyl-glycero-phosphatidylcholine 
DMPC:  Dimyristoyl-glycero-phosphatidylcholine 
Cav1:  Caveolin-1 
WT:  wild type 
IPA:  Isopropanol 
PCR:  Polymerase Chain Reaction 
LB:  Luria-Bertani media 
MDAG:  minimal media supplemented with amino acids 
KAN:  Kanamycin 
IPTG:  Isopropyl β-D-1-thiogalactopyranoside 
EDTA:  Ethylenediaminetetraacetic acid 
TAE:  Tris-acetate EDTA buffer 
DPH:  1,6-diphenyl-1,3,5-hexatriene 
C8E5: pentaethylene glycol monooctyl ether (n-octylpentaoxyethylene) 
 xviii 
NMR: Nuclear Magnetic Resonance Spectrometry 
HSQC: Heteronuclear Single Quantum Coherence Spectroscopy 
TROSY: Transverse Relaxation-Optimized Spectroscopy 
 
 1 
 
 
ABSTRACT 
 
Membrane proteins represent an important class of proteins that closely 
associate or reside within the plasma membrane of the cell. They play a multitude of 
roles in cell function such as signaling, trafficking, and recently discovered, scaffolding 
and shaping of the plasma membrane itself.  For example, caveolin is a membrane 
protein that is believed to have the ability to curve the plasma membrane forming 
invaginations that serve as signaling platforms called caveolae. The curvature of the 
plasma membrane is believed to be a result of caveolin oligomerization.  Caveolin 
oligomerization was characterized using sedimentation equilibrium analytical 
ultracentrifugation. Due to the extremely hydrophobic nature of caveolin it was 
necessary to explore different detergents and lipid systems that support membrane 
protein structure and function.  Not all detergents are conducive to studies of membrane 
proteins and it is often necessary to determine empirically the best detergent / lipid 
mimic best suited for biophysical studies.  One membrane mimic that has been well-
characterized and used successfully to study membrane proteins are bicelles.  Bicelles 
are discoidal phospholipid structures comprised of a long-chain and short-chain 
phospholipid, typically 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dihexanoyl-sn-glycero-3-phosphocholine (DHPC), respectively. Bicelles provide a true 
bilayer environment in which to study membrane protein structure and function. These 
lipid structures were successfully density matched using the method of sedimentation 
equilibrium in the analytical ultracentrifuge by adding 71.7% D2O as a density modifier.  
We explored the utility of bicelles as a medium for studying membrane protein 
interactions in the analytical ultracentrifuge (AUC) by investigating the interactions of 
caveolin-1. The results of this work show that caveolin-1 does not have the capacity to 
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oligomerize in detergent micelles or in a bilayer environment (bicelles). On the other 
hand, a naturally-occuring breast cancer mutant, P132L, forms a strong dimer in 
detergent micelles.  A close investigation of the mutant reveals that an extension of helix 
2 in the intramembrane region of the protein where dimerization was shown to occur 
may play a key role in the dimerization of the mutant.   
An alternative bicelle system was also investigated using pentaethylene glycol 
monooctyl ether (C8E5) instead of DHPC to form the rim of the bicelle.  The C8E5 / DMPC 
lipid aggregates were density matched and their properties were characterized using 
31P-phosphorus NMR to assess the heterogeneity of the lipid / detergent arrangement, 
which confirms a bicellar-like arrangement.  C8E5 has a density similar to water (1.007 g / 
mL) and was shown to form lipid aggregate structures with DMPC that are less dense 
and require significantly lower quantity of D2O to density match in the AUC making them 
better suited to the study of membrane protein interactions of small peptides. 
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Chapter  1.  Membrane Protein Biochemistry 
 
 
INTRODUCTION 
 
Membrane Proteins 
 
 Proteins are the foundation for all living organisms.  These soluble 
macromolecules are very diverse in both structure and function.  One special class of 
proteins called membrane proteins are encoded for in approximately one-third of most 
mammalian genomes.  Though they are fewer in number compared to their soluble 
counterparts, their importance is not to be underestimated.  Membrane proteins describe 
proteins that interact with the plasma membrane of cells; although, not all membrane 
proteins interact with the lipid bilayer of the plasma membrane in the same way.  
Membrane proteins can be divided into three broad classes: peripheral, integral, and 
lipid-anchored (Figure 1-1).  Peripheral membrane proteins interact with the plasma 
membrane of cells superficially where only a small portion of the protein is in contact 
with the lipids of the bilayer.  These proteins can typically be extracted using traditional 
biochemical techniques and are often soluble in aqueous buffers.  Lipid-anchored 
proteins are soluble in aqueous buffers as well, and are only anchored to the plasma 
membrane through the covalent attachment of a lipid (i.e. palmitoylation) or a glycolipid 
(i.e. glycophosphatidylinositol (GPI-anchored)) (Figure 1-1).  Integral membrane proteins 
are embedded in the lipid bilayer of the plasma membrane (Figure 1-1).  The extent to 
which integral membrane proteins associate with the lipids varies.  Integral membrane 
proteins are a particularly challenging group of proteins to study due to their extreme 
hydrophobicity.  Their extreme hydrophobicity is due to the need to situate the majority 
of their polypeptide backbone in the hydrophobic side of the lipid bilayer.  Examples of 
some of the most highly studied integral membrane proteins include bacteriorhodopsin 
 4 
and G-protein coupled receptors.  Because integral membrane proteins are so closely 
associated with the plasma membrane, their chemical properties highly differ from those 
of soluble proteins.  The most distinguishing feature of membrane proteins is that they 
have a high fraction of non-polar amino acid residues.  These non-polar residues impart 
a high degree of hydrophobicity to membrane proteins making them very challenging to 
study using traditional biochemical techniques.  Biochemical and biophysical techniques 
such as analytical ultracentrifugation, solution NMR, and chromatography have been 
adapted to the study of these proteins, but it is often necessary to modify these 
techniques empirically to make them suitable to the study of new membrane proteins. 
 
 
Integral Polytopic
Membrane Associated / 
Peripheral 
Lipid Anchored
 
 
 
Figure 1-1. Schematic representation of three different classes of membrane 
proteins. 
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Detergents and Lipids are Used in Studies of Membrane Proteins 
 Membrane proteins reside in a lipid bilayer inside the plasma membrane.  This 
lipid bilayer is crucial to the stability and integrity of membrane protein structure.  In order 
to study membrane proteins, it is necessary to carry out these studies using a lipid-like 
environment so that the structure and behavior of the membrane protein under scrutiny 
is preserved.  Detergents provide a powerful medium in which to study membrane 
proteins.  These amphipathic molecules typically consist of a long hydrophobic carbon 
chain and highly hydrophilic headgroup (Figure 1-2a).  When these molecules are 
exposed to water they spontaneously assemble into aggregates called micelles (Figure 
1-2a).  Micelles facilitate the dissolution of membrane proteins in aqueous buffers by 
enshrouding the hydrophobic portion of the membrane protein with the hydrophobic lipid 
tails thereby protecting it from the surrounding aqueous environment.  Micelles are a 
powerful medium in which to study membrane protein structure and function; however, 
they can project undesirable properties onto proteins.   
Detergents can either be non-ionic, cationic, anionic, or zwitterionic.  Non-ionic 
detergents such as Triton X-100 are more mild and tend to be less denaturing than ionic 
detergents, although they are not always powerful enough to solubilize highly 
hydrophobic membrane proteins.  Ionic detergents such as sodium dodecylsulfate 
(SDS), a powerful anionic detergent, can be used to solubilize membrane proteins, 
however, it is also highly denaturing (1).  Zwitterionic detergents such as 
dodecylphosphocholine (DPC) and lyso-myristoylphosphatidylglycerol (LMPG) are 
powerful enough to solublize hydrophobic proteins, and they have been used with 
success in partial protein structure determination (2, 3).  Other micellar systems employ 
the use of short-chain phospholipids such as dihexanoylphosphatidylcholine (DHPC), 
which have been successfully used in determination of membrane protein structure (4, 
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5).  Clearly, micellar systems have been used successfully in the study of membrane 
protein structure and function.  However, micellar systems must be used with caution 
when studying membrane proteins.  They are highly curved structures which have the 
potential to influence elements of protein structure due to the high curvature.  In some 
cases, protein structure can be altered enough that it can affect the activity of proteins, in 
particular, enzymes.  The enzymatic activity of proteins can be affected by the nature of 
the detergent in which it resides (6).  Lastly, although micelles have become an 
invaluable tool in which to study membrane proteins, they do not provide a true bilayer 
environment, which can complicate data interpretation under certain circumstances.  
Nonetheless, micellar systems have been used to obtain valuable information about 
membrane proteins (5).   
 In addition to micelles, two other systems that have been explored for the study 
of membrane proteins are vesicles and bicelles.  Vesicles are often comprised of 
phospholipid molecules such as dimyristoylphosphatidylcholine (DMPC) which differ 
from detergent molecules in that they contain two fatty acid tails rather than one (Figure 
1-2b).  Phospholipid molecules are amphipathic and spontaneously form bilayers in an 
aqueous environment.  When compared to micelles, vesicles are larger lipid aggregates 
that have a distinct cavity inside that is similar to a real cell.  The inside cavity of vesicles 
is aqueous and membrane proteins can be incorporated into the bilayer region of 
vesicles (7). Vesicles are not equilibrium structures meaning that lipid molecules are not 
in flux with their vesicle counterpart.  This can be undesirable when studying membrane 
protein interactions because the protein is not free to interact with other proteins.   
To capture the bilayer feature of cells and maintain a dynamic system that 
supports protein interactions, bicelles have emerged as a powerful tool.  Bicelles are 
discoidal lipid aggregates that are comprised of a long chain phospholipid like DMPC, 
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and short-chain phospholipid such as DHPC (Figure 1-2b).  The size of bicelles can be 
tailored to different applications simply by adjusting the mole ratio, q, of the long chain 
lipid, DMPC, to that of the short chain lipid, DHPC.  This ratio is also affected by the 
overall lipid concentration (cL).  In most applications, a q of 0.5 to 3.0 is used.  The 
bilayer thickness can also be adjusted by changing the length of the long chain lipid that 
is used.   
q = moles of DMPC / moles of DHPC 
 
 
 
 
 
      
Bilayer region
(DMPC)
Rim
(DHPC)
DMPC
DHPC
DPC
SDS
LMPG
a. b.
Figure 1-2. a) Schematic diagram of a micelle and common detergents that form 
them.  DPC = dodecylphosphocholine, SDS = sodium dodecyl sulfate, LMPG = lyso-
myristoylphosphatidylglycerol b) Schematic diagram of a bicelle and two common 
phospholipids that comprise bicelles.  
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  Of the three different systems, bicelles share the advantages of micelles in that 
they are dynamic and allow proteins to freely associate thereby supporting any inherent 
protein interactions, yet they also provide a bilayer environment for the study membrane 
proteins, which is a more accurate reflection of the natural membrane environment of 
membrane proteins. Bicelles have been successfully used as a tool in which to study 
membrane protein structure (8).  Their utility as a medium in which to study membrane 
protein interactions is only beginning to emerge.  Traditionally, membrane protein 
interactions have been evaluated in micellar systems (9, 10, 11).  While the information 
gleaned from these studies has been insightful, the uncertainty or inaccuracies 
inherently presented by a micelle system cannot be avoided.  The use of bicelles as a 
means of studying membrane protein interactions in a true bilayer, this would eliminate 
the uncertainty or bias present in the use of micelles.  The goal of the work presented in 
the following dissertation is to explore the utility of bicelles in the study of membrane 
protein interactions.  Bicelles will be used to characterize the oligomeric behavior of the 
integral membrane protein, caveolin. 
      
 
 
 
 
 
  
 9 
 
Caveolae and Caveolin 
 Caveolae (plural, caveola singular) are a feature of mammalian cells which have 
gained much attention over the last two decades.  They are non-clathrin coated 
indentations of the plasma membrane that are approximately 50-100 nm in diameter and 
are found in many different cell types but are particularly abundant in smooth muscle 
cells, skeletal muscle cells, endothelial cells, fibroblasts and adipocytes (12).  These 
flask-like structures consist of a myriad of proteins that work together to mediate the 
dynamic signaling and trafficking platforms that are the hallmark of caveolae (13, 14, 15, 
16, 17, 18, 19, 20).  Caveolin is a 21-24 kDa integral membrane protein that is central to 
caveolae formation.  It is the single most abundant protein found in caveolae and when 
this protein is not present, caveolae are unable to form (13).  Not only are caveolae 
unable to form when caveolin is not present, caveolae can also be introduced to 
lymphocytes, which normally do not express caveolin, by transforming these cells with 
the caveolin gene (21).   
 Three isoforms of caveolin have been identified; 1, 2, and 3, yet caveolin-1 is by far 
the most ubiquitous.  Caveolin-2 is not as abundant as caveolin-1 and its role in 
caveolae formation is less understood; however, it does appear to associated very 
closely with caveolin-1.  Caveolin-3 is most commonly found in smooth and skeletal 
muscle cells and it is not as ubiquitous as caveolin-1.  Caveolin-3 is specific to skeletal 
muscle cells, cardiac myocytes, and smooth muscle cells (22, 23, 24, 25).  Like caveolin-
1, caveolin-3 is sufficient to support caveolae formation; when caveolin-3 is over-
expressed in transgenic mice an increase in muscle cell caveolae is observed (26).  All 
three caveolin isoforms show a high degree of sequence homology; however, caveolin-1 
and -3 have the highest degree of homology (Figure 1-3).  One distinguishing feature 
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between the three caveolin isoforms is that the soluble N-terminal region of each protein 
varies in length.  The membrane interacting region of all three proteins, the portion of the 
protein that is predicted to be buried within the lipid bilayer of the plasma membrane, is 
highly conserved (Figure 1-3).  This suggests that the intramembrane region is critical to 
the function of the protein and without it, caveolin does not function properly. 
 
 
 
 
 
 
 
 Caveolin-1 1   MSGGKYVDSE GHLYTVPIRE QGNIYKPNNK AMADELSEKQ 40 
Caveolin-2 1                  MGLETE KADVQLFMDD DSYSHHSGLE 26 
Caveolin-3 1                                MMA EEHTDLEAQI 13 
 
Caveolin-1 41  VYDAHTKEID LVNRDPKHLN DDVVKIDFED VIAEPEGTHS 80 
Caveolin-2 27  YADPEKFADS DQDRDP-HRL NSHLKLGFED VIAEPVTTHS 66 
Caveolin-3 14  VKDIHCKEID LVNRDPKNIN EDIVKVDFED VIAEPVGTYS 53 
 
Caveolin-1 81  FDGIWKASFT TFTVTKYWFY RLLSALFGIP MALIWGIYFA 120 
Caveolin-2 67  FDKVWICSHA LFEISKYVMY KFLTVFLAIP LAFIAGILFA 105 
Caveolin-3 54  FDGVWKVSYT TFTVSKYWCY RLLSTLLGVP LALLWGFLFA 93 
 
Caveolin-1 121 ILSFLHIWAV VPCIKSFLIE IQCISRVYSI YVHTVCDPLF 160 
Caveolin-2 106 TLSCLHIWIL MPFVKTCLMV LPSVQTIWKS VTDVIIAPLC 145 
Caveolin-3 94  CISFCHIWAV VPCIKSYLIE IQCISHIYSL CIRTFCNPLF 133 
 
Caveolin-1 161 EAVGKIFSNV RINLQKEI 178 
Caveolin-2 146 TSVGRCFSSV SLQLSQD  162 
Caveolin-3 134 AALGQVCSSI KVVLRKEV 151 
Figure 1-3. Sequence alignment of three caveolin isoforms 1, 2, 3.  Dark gray 
highlights conserved amino acid residues.  Light gray highlights similar amino 
acid residues. 
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Caveolin and Disease 
 
Cancer 
 Many biological studies aimed at investigating changes in protein expression levels 
in abnormal cells have uncovered a link between changes in normal caveolin expression 
and the development and progression of different diseases.  Caveolin expression levels 
are altered and mutations are found in diseases such as heart disease, Alzheimer’s 
disease, muscular dystrophy, diabetes, and cancer (27, 28, 29, 30, 31).  The exact role 
caveolin plays in the development of these diseases remains ambiguous, which further 
emphasizes the need for more studies to understand how caveolin is linked to these 
diseases.   
 Caveolae are intimately connected to cell signaling processes and it is possible that 
mutations to the caveolin protein or changes in the expression levels result in the 
disruption of key signaling events in the cell which can lead to various disease states.  
For example, mutations to caveolin and changes in expression levels have been linked 
to breast cancer recurrence and metastasis.  One particular mutation that has been 
heavily investigated due to its strong association to breast cancer development is 
caveolin-1 P132L.  This mutant is found in approximately 16% of breast cancers (32).  In 
vivo the P132L mutant localizes to the Golgi apparatus, and it also acts as a dominant 
negative mutation whereby it leads to the retention of wild-type caveolin-1 when both are 
mutually expressed (27, 33).  The retention of caveolin-1 P132L in the Golgi apparatus 
results in a loss of caveolae from the plasma membrane.  The P132L mutant 
upregulates ERα receptor and this mutant is present in approximately 19% of ERα-
positive breast cancers which is linked to aggressive breast carcinomas (27, 34).  In 
addition to the P132L mutation, six other point mutations in caveolin were isolated from 
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breast cancer tissue, but P132L is by far the most commonly occurring mutant and the 
most studied due to its strong presence and association with breast cancer (34).    
Alzheimer’s Disease 
 Alterations in caveolin expression and function have been linked to other diseases as 
well including Alzhemier’s disease.  In senile plaques of Alzheimer’s patients an 
upregulation of caveolin-3 was observed in the cells surrounding these plaques.  
Immunoprecipitation experiments reveal that caveolin-3 co-localizes with amyloid pre-
cursor protein (APP) both in vivo and in vitro, and the over-expression of caveolin-3 in 
cultured cells stimulates β-secretase-mediated cleavage of APP.  The product of β-
secretase cleavage has direct implications for the development of Alzheimer’s disease 
(35, 36).   
Heart Disease 
 The tight regulation of caveolin-1 and -3 is also crucial to proper physiological heart 
function and deviations from controlled caveolin expression levels leads to cardiac 
myopathies.  For example, when caveolin-3 levels were quantified from the cardiac 
myocytes of canines with heart disease, caveolin-3 levels were elevated (37).  Caveolin-
3 over-expression in transgenic mice show severe cardiac tissue degeneration, fibrosis, 
and impaired cardiac function and also leads to the down-regulation of nitric oxide 
synthase (29).  Interestingly, a P104L mutant of caveolin-3 leads to impaired calcium 
channel function in skeletal muscle cells (38).  This P104L mutant is arguably 
synonymous to the P132L mutant that was identified in caveolin-1. 
Diabetes 
 Caveolin-1 expression has been linked to insulin signaling in diabetes.  Insulin co-
localizes within caveolae and has been shown to recruit caveolin-1 to plasma membrane 
(39, 40). In hyperglycemic rats, alveolar epithelial cells were found to contain a 1.3-fold 
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higher level of caveolae, which is accompanied by higher caveolin-1 expression levels, 
and when caveolin-null mice were evaluated significant increases in insulin resistance 
were observed along with impairment of glucose uptake by skeletal muscle cells in mice 
(41, 42).  When the expression of this protein was restored in diabetic obese mice 
improvements to glucose metabolism followed (42, 43).  Caveolin is an integral player in 
the maintenance of normal cell function and it is clear that mutations and alterations in 
expression levels can lead to the development and progression of disease.       
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Caveolin Structure 
 Caveolin has been described as possessing regions or domains based on its primary 
sequence analysis: An N-terminal domain, a scaffolding domain, a highly insoluble 
intramembrane domain, and a C-terminal domain.  The N-terminal domain consists of 
mostly polar amino acid residues making this region extremely soluble (Figure 1-4).  
Following the N-terminal domain is a small region comprised of both polar and non-polar 
amino acids called the scaffolding domain (Figure 1-4).  This region of the protein is very 
small compared to the other regions described in the caveolin protein.   
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Figure 1-4. Schematic diagram of the proposed regions of the 
caveolin-1 protein. 
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Though it has been well-studied, its role remains ambiguous.  It has been charged with 
binding caveolin to the plasma membrane, and it has been described as an 
oligomerization platform where many caveolin proteins come together to form a caveola 
(44, 45, 46, 47).  Succeeding the scaffolding domain is a sequence of hydrophobic 
amino acids called the intramembrane domain which is proposed to be entirely situated 
in the plasma membrane (Figure 1-4).  A careful analysis of the primary sequence of all 
three caveolin isoforms reveals that this region is comprised entirely of hydrophobic 
amino acid residues, which suggests that it is embedded almost entirely in the lipid 
bilayer of the plasma membrane.  The C-terminal domain of caveolin is also comprised 
of polar and non-polar amino acids which are predicted to form an amphipathic helix 
that, like the scaffolding domain, also rests on the surface of the plasma membrane 
(Figure 1-4).  This region has also been described as an attachment site for caveolin to 
the plasma membrane (45). 
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 The intramembrane domain is a particularly intriguing region of the caveolin protein.  
Preliminary studies probing the location of the caveolin protein in cells revealed that the 
N- and C- termini lie on the same side of the plasma membrane (48, 49, 50).  From 
these studies it can be inferred that caveolin forms a turn in the lipid bilayer of the 
plasma membrane.  Also, a mechanism of caveolae curvature can be hypothesized: If 
caveolin only inserts partially into the plasma membrane, this creates an asymmetric 
displacement of the lipids on the inner leaflet of the membrane while pushing the lipids of 
the outer membrane leaflet closer together causing the membrane to curve (Figure 1-5).  
When multiple caveolin proteins come together, self-associate, or oligomerize, this event 
leads to the creation of the observed caveolar invaginations.  It is not clear how many 
caveolin proteins associate to form a single caveola.   
 
 
 
 
Intracellular 
space
caveolin
50-100 nm
Extracellular Space 
Figure 1-5. Proposed mechanism of caveolin induced membrane 
curvature. 
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Caveolin Oligomerization 
 Studies of the caveolin protein are heavily aimed at investigating the effects of 
caveolin in cell signaling and its effect on organism pathology in animal models.  
Expression and knockout studies of the protein were employed to determine the effects 
of caveolin on caveolae formation, signaling, and animal physiology (51, 52, 53, 54, 55).  
The results of these studies demonstrate a clear causal relationship between impaired 
caveolin function and aberrant organism physiology.  However, they are unable to 
address the exact role that caveolin plays in normal cellular function.  Studies aimed at 
looking closely at the precise role of caveolin focused on isolating and characterizing the 
protein.  Caveolin was first isolated from cells using a sucrose density gradient 
containing a mild detergent such as Triton X-100.  Caveolin migrates with the Triton X-
100 insoluble fraction.  By isolating the Triton X-100 insoluble fractions from whole cell 
lysates, and using a combination of SDS-PAGE and western blot analysis to probe for 
the presence of caveolin, it was found that caveolin could be isolated in 200, 400, and 
600 kD molecular weight complexes which were characterized by SDS-PAGE (47, 48, 
56).  Based on these findings it was concluded that caveolin self-assembles into high-
order oligomers, which may drive the formation of caveolae.  Although insightful, these 
studies do not account for the presence of other biomolecules in the large complexes 
because only the caveolin protein was probed for, and the role of other molecules 
cannot be accounted for.  With this limitation in mind definitive conclusions about the 
oligomeric state of caveolin cannot be drawn.    
 In biology studies, caveolin has been isolated in large insoluble complexes from 
cells.  Based on these studies, it was believed that caveolin oligomerizes to form the 
observed high molecular weight complexes leading to the creation of caveolae in cells.  
The full characterization of all molecules present in these complexes had not been 
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accomplished and isolating caveolin from these complexes was likely difficult due to the 
highly insoluble nature of the complexes.  Further attempts to characterize the 
oligomeric state using biochemical methods have been limited to soluble pieces of the 
protein.  For example, residues 1-62 do not have any oligomeric properties, yet residues 
1-82 oligomerize into a heptameric complex (46).  This data led to the conclusion that 
the scaffolding domain was responsible for the oligomerization of caveolin-1.  However, 
in this study there were no detergents or lipid mimics present in this study the lack of 
which can lead to aggregation.  Other studies suggest that the C-terminal domain may 
be responsible for the oligomerization (57).  Definitely conclusions from this study are 
difficult to formulate because the C-terminal region of does not necessarily capture the 
true nature of caveolin.  
 The main objective of this work is to characterize the precise oligomeric state of 
caveolin using biophysical techniques.  If caveolin forms high-order oligomers, then it is 
reasonable to believe that the intramembrane region plays a critical role.  To explore this 
hypothesis current biophysical techniques were adapted to the study of membrane 
proteins.  These studies are outlined in Chapters 2 through 5.  Chapter 6 describes the 
expression and purification of membrane proteins from E. coli and the subsequent 
methods used to reconstitute these highly hydrophobic proteins into lipid bilayers.   
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Introduction to Analytical Ultracentrifugation 
 
Analytical ultracentrifugation is a powerful tool that is used to study the hydrodynamic 
and thermodynamic properties of proteins.  Two types of experiments can be executed 
to measure these parameters: sedimentation velocity and sedimentation equilibrium.  
The former can be used to determine the size and shape of proteins that are traveling 
down a solution column.  The latter is used to measure protein interactions and 
determine stoichiometric ratios of hetero-interactions as well as oligomeric states.  In the 
membrane protein field, sedimentation velocity experiments incur challenges when 
detergents are present.  Protein size and shape can be heavily influenced when it is 
enshrouded in detergent and lipid molecules.  The presence of lipid and detergent 
molecules can inflate the protein size and distort information about protein shape.  
Because of the bias introduced when working in a detergent or lipid system, 
sedimentation equilibrium experiments are much more useful in membrane protein 
studies because typically the oligomeric state of the protein is of interest.  Sedimentation 
equilibrium experiments differ from velocity experiments, because instead of measuring 
the time it takes for a protein to travel down a solution column it measures the 
concentration profile created by a protein at equilibrium.  In other words, the forces 
acting on the sedimenting protein, diffusion and gravity, are balanced by one another 
and the protein no longer moves down the solution column.  The mathematical 
expression that has been derived to describe the equilibrium concentration profile of a 
protein is called the Lamm equation: 
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From the Lamm equation, the molecular weight of a protein, M, can be calculated by 
measuring its absorbance at 280 nm, which is directly related to the concentration of the 
protein, c, at a given radius from the center axis of rotation, r.  The density of the 
solution, ρ, is known as well as the angular velocity, ω, which can be determined from 
the centrifugal force measured in revolutions per minute (rpm).  The ideal gas constant, 
R, and the temperature, T, in Kelvin are also used to describe an ideally sedimenting 
species.  Lastly, the partial specific volume of the protein, ν, is determined from the 
method of Cohn and Edsall where the average of the sum of the partial specific volumes 
of each amino acid in the protein sequence is used to determine the overall partial 
specific volume of the protein (58).  Sedimentation equilibrium is advantageous to other 
methods used to evaluate protein interactions, because it allows interactions to be 
observed in solution without modifications to the protein.  With the advent of computers 
which can facilitate the processing of large quantities of data, analytical 
ultracentrifugation is becoming a powerful tool to characterize protein interactions.  In 
particular, sedimentation equilibrium presents significant advantageous to study 
membrane protein interactions, because the bias introduced by the presence of 
detergents can be circumvented. 
 Membrane proteins are highly insoluble and spend their time interacting closely with 
the plasma membrane of cells.  In order to study these types of proteins it is crucial to 
use a suitable membrane mimic that will both facilitate the solubility of these highly 
hydrophobic proteins in aqueous buffers and that will provide the same stability and 
support of the native plasma membrane.  Detergents are employed because of their 
amphipathic properties, which is similar to the plasma membrane of cells.  Detergents 
contain a hydrophilic carboxylate headgroup that is attached to a hydrocarbon tail 
resembling the phospholipids found in the native plasma membrane.  They 
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spontaneously aggregate to form micelles, which are dynamic systems meaning that the 
lipid aggregate is in constant equilibrium with monomeric detergent molecules.  This is 
ideal when studying membrane proteins because it supports native protein interactions.  
Sedimentation equilibrium is ideal for studying membrane proteins in detergent systems 
because the method of density matching can be employed to subtract away the 
molecular weight contribution of the lipid or detergent aggregate to the protein. 
 Most density matching studies that have been carried out employ the use of a 
detergent to analyze protein interactions.  For example, studies of the anti-apoptotic 
membrane protein Bcl-xL were carried out dodecylphosphocholine (DPC) micelles.  In 
this study, sedimentation equilibrium density matching experiments were carried out 
according to the method of Tanford and Reynolds (59).  In this method it was determined 
that approximately 52.5% D2O is necessary to successfully subtract out the molecular 
weight contribution of DPC to the Bcl-xL protein (60).  Other studies have utilized 
detergents such as C8E5 and C12E8 as well to determine the oligomeric state of the 
protein, glycophorin A.  In this study, no density modifier was required since the density 
of the detergents are approximately equal to the density of the buffer (61).  
 Not all detergents are suited to analytical ultracentrifugation studies.  The most 
commonly used detergents like C8E5, C12E8, and DPC are unique in that the densities of 
these detergents is very close to that of water, approximately 1.0 cm3 / g.  As detergents 
deviate further from the density of water, it is necessary to use larger quanitites of 
density modifiers such as D2O, glycerol, and sucrose.  It is possible for the density of the 
detergent to exceed the density of 100% D2O (greater than 1.10 g / cm3) in which case it 
may be necessary to use heavier isotopes of water such as D2O18.  DPC micelles are 
often used in analytical ultracentrifugation for two reasons: DPC is powerful enough to 
reconstitute highly hydrophobic proteins, and DPC is often used in NMR studies where 
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protein structures have been accurately solved (62, 63).  Because DPC is often used in 
structural studies of proteins it has the ability to preserve important structural features of 
proteins.     
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Chapter 2.  Analysis of Caveolin-1 Oligomerization in DPC Micelles 
ABSTRACT 
Caveolin-1 is the most important protein found in caveolae, which are cell surface 
invaginations of the plasma membrane that act as signaling platforms. A single point 
mutation in the transmembrane domain of caveolin-1 (proline 132 to leucine) has 
deleterious effects on caveolae formation in vivo, and has been implicated in various 
disease states, particularly aggressive breast cancers. Using a combination of gel 
filtration chromatography and analytical ultracentrifugation we found that a fully-
functional construct of caveolin-1 (Cav1(62–178)) was a monomer in 
dodecylphosphocholine micelles. In contrast, the P132L mutant of Cav1(62–178) was 
dimeric. To explore the dimerization of the P132L mutant further, various truncated 
constructs (Cav1(82–178), Cav1(96–178), Cav1(62–136), Cav1(82–136), Cav1(96–
136)) were prepared which revealed that oligomerization occurs in the transmembrane 
domain (residues 96–136) of caveolin-1. To characterize the mutant structurally, 
solution-state NMR experiments in lyso-myristoylphosphatidylglycerol were undertaken 
of the Cav1(96–136) P132L mutant. Chemical shift analysis revealed that compared to 
the wild type, helix 2 in the transmembrane domain was lengthened by four residues 
(wild type, residues 111 to 129; mutant, residues 111–133), which corresponds to an 
extra turn in helix 2 of the mutant. Lastly, point mutations at position 132 of Cav1(62–
178) (P132A, P132I, P132V, P132G, P132W, P132F) revealed that no other 
hydrophobic amino acid can preserve the monomeric state of Cav1(62-178) which 
indicates that proline 132 is critical in supporting proper caveolin-1 behavior. 
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INTRODUCTION  
 Caveolae are a feature of mammalian cells which have been the subject of heavy 
investigation over the last two decades.  They are non-clathrin coated indentations of the 
plasma membrane that are approximately 50-100 nm in diameter and they are intimately 
involved in molecular trafficking (1).  Caveolae are highly ubiquitous and they can be 
found in most differentiated cell types ranging from smooth muscle cells to adipocytes.  
They are particularly abundant in adipocytes where they shuttle lipids and other 
signaling molecules across the plasma membrane (2, 3).  Aside from lipid transport 
caveolae are also involved in calcium signaling and cell-cell communication (4, 5, 6, 7, 8, 
9).  Caveolae are comprised of a myriad of proteins and other biomolecules, and they 
are enriched with cholesterol and sphingolipids, which makes their composition unique 
from the bulk plasma membrane (10, 11).  Although they have been compared to lipid 
rafts, caveolae are unique and often differentiated from lipid rafts by their ability to 
endocytose into cells.    One of the first studies investigating mechanisms of caveolae 
transport uncovered the presence of one particularly abundant protein which became 
known as caveolin (12).  Caveolin is the most important protein found in caveolae and it 
is vital to the creation of caveolae.  When caveolin expression is silenced, caveolae are 
completely abolished from the surface of cells (13, 14).  Caveolae can also be induced 
de novo in lymphocytes when non-native caveolin expression is introduced, which 
suggests that caveolin is necessary and sufficient for the formation of caveolae (15).  
Three isoforms of caveolin have been identified: 1, 2, 3, yet caveolin-1 is by far the most 
ubiquitous and it, alone, is sufficient to form caveolae. Caveolin-2 is not as abundant as 
caveolin-1 and its role in caveolae formation is much less understood than caveolin-1, 
though, it has been suggested that both isoforms hetero-oligomerize.  Caveolin-3 is 
commonly referred to as “muscle specific” caveolin and it is found in high abundance in 
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skeletal muscle cells (14).  All three caveolin isoforms show a high degree of sequence 
homology with caveolin-1 and -3 having the highest degree of homology.  The soluble 
region of each caveolin protein varies in length; however, the membrane interacting 
regions of all three proteins are highly conserved.   
 Caveolin oligomerization is thought to contribute to caveolae formation by inducing 
and stabilizing the curvature of the plasma membrane.  When isolated in vivo from a 
sucrose density gradient containing a mild detergent like Triton X-100 caveolin migrates 
with the Triton X-100 insoluble material.  By isolating the Triton X-100 insoluble fractions 
from whole cell lysates, and using a combination of SDS-PAGE and western blot 
analysis to probe for the presence of caveolin, it was found that caveolin could be 
isolated in 200, 400, and 600 kD molecular weight complexes by SDS-PAGE (16).  
Chemical cross-linking studies further reveal that caveolin self-associates into dimers, 
trimers and tetramers in addition to the high-molecular weight complexes that were 
previously observed (16).  From these results it is believed that the extreme curvature of 
caveolae may be a direct consequence of high-order homo-oligomer formation of 
caveolin.  Furthermore, the membrane curvature is thought to be stabilized by these 
large caveolin complexes. The precise characterization of the oligomeric state of 
caveolin in these complexes is difficult to achieve because it is unclear if other 
biomolecules are present. Attempts to characterize the oligomeric state using 
biophysical methods have focused on soluble pieces of the protein. For example, 
residues 1-62 do not have any oligomeric properties, yet residues 1-82 oligomerize into 
a heptameric complex (17).  This data led to the conclusion that residues 82-101, also 
called the “scaffolding domain”, were responsible for the oligomerization of caveolin-1.  
Other studies suggest that the C-terminal region of the protein contains elements 
involved in oligomerization as well.  When a GST fusion of the C-terminal domain of 
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caveolin-1 (residues 135-178) was co-expressed with the full-length protein, the C-
terminal domain co-immunoprecipitates, indicating that it may bind to or oligomerize with 
the full-length caveolin protein.  Based on the results of this study, the C-terminal region 
of caveolin-1 influences oligomerization (18).  Although work in the area of caveolin-1 
oligomerization has offered useful insight into caveolin behavior, a direct and precise 
characterization of caveolin oligomerization is lacking which leaves the answer to this 
question ambiguous and unclear.  The goal of this study is to characterize the homo-
oligomeric interaction of caveolin-1 in a biologically relevant medium using a 
combination of gel filtration chromatography and sedimentation equilibrium analytical 
ultracentrifugation.  Further, the goal is to assess the strength of the observed 
interactions from the data.  
 Caveolin has been closely linked to a number of disease states including heart 
disease, Alzheimer’s, and cancer.  A naturally occurring point mutation (P132L) in the 
caveolin-1 gene is present in approximately 16% of breast cancers, and has been 
closely linked to increased recurrence and metastasis (19, 20).  In addition, this mutant 
appears to be functionally different from the wild-type as it is retained in the Golgi 
apparatus of cells and does not get transported to its final destination in the plasma 
membrane resulting in the elimination of caveolae from the surface of cells (21).  
Interestingly, the P132L mutant appears to behave in a dominant negative manner:  
When both the P132L mutant and wild-type caveolin are co-expressed, both become 
localized to the Golgi, which is a fate common to misfolded proteins (21).  Furthermore, 
a study by Bonuccelli et al demonstrates that when caveolin-1 P132L is expressed in 
Met-1 cells, it acts as a loss-of-function mutation and promotes recurrence of breast 
cancer (19).  The second goal of this study is characterize the oligomeric state of the 
caveolin-1 P132L mutant and determine if the wild-type and mutants show differences in 
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their behavior at the atomic level. 
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MATERIALS AND METHODS 
 
Protein Expression and Purification 
 The DNA for Cav1(62-178) was synthesized by Genscript Corporation (Piscataway, 
NJ).  Caveolin-1 has three sites of cysteine palmitoylation (C133, C143, C156) that have 
been shown to be nonessential for proper caveolin-1 folding and trafficking (22, 23, 24).  
Therefore, each cysteine was mutated to serine to avoid unwanted and biologically 
irrelevant disulfide bonding.  The Cav1(62-178) gene was cloned, over-expressed, and 
purified as described in Diefenderfer et al (25).  After HPLC purification, 30 mg of dried 
Cav1(62-178) was dissolved in 3 mL of hexafluoroisopropanol followed by the addition of 
7 mL of deionized water.  The solution was flash frozen and lyophilized.  MALDI-TOF 
analysis confirmed the identity of the final protein product.  Truncated and mutant 
constructs were prepared using the same procedure described above.  The truncated 
wild-type and P132L mutant constructs prepared were residues: 82-178, 82-136, 96-
178, 96-136, 62-136.  The mutant constructs prepared were Cav1(62-178): P132L, 
P132A, P132G, P132W, P132F, P132V, P132I. 
 
Gel Filtration Chromatography 
 To 0.8 mg of lyophilized Cav1(62-178), 1.0 mL of buffer (20 mM HEPES pH 7.4, 150 
mM NaCl, and 50 mM DPC (Anatrace, Maumee, OH)) was added followed by three 
minutes of vigorous vortexing.  Next, the resultant clear solution was filtered through a 
0.2 µm spin filter and injected onto a Sephacryl-300HR 16/60 column (GE Healthcare, 
Piscataway, NJ) equilibrated with buffer (20 mM HEPES pH = 7.4, 150 mM NaCl and 5 
mM DPC).  The column was calibrated using alcohol dehydrogenase, carbonic 
anhydrase, α-amylase, bovine serum albumin, and cytochrome c oxidase, and the 
elution profile was monitored at 280 nm.  All truncated and mutant constructs were run in 
an identical fashion. 
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Analytical Ultracentrifugation 
 0.8 mg of lyophilized Cav1(62-178) was reconstituted into a density-matched buffer 
comprised of 20 mM HEPES pH 7.4, 100 mM NaCl, 50 mM DPC and 52.5 % (v/v) D2O.  
DPC micelles were matched using a D2O concentration of 52.5% (v/v) in a solution of 20 
mM HEPES 100 mMNaCl pH = 7.4 (26).  Each protein sample was prepared at three 
concentrations (30 µM, 15 µM, and 7.5 µM), and verified using the BCA Assay (Pierce 
Protein Research Products, Rockford IL).  The samples were loaded into a six-sector 
charcoal-filled epon centerpiece (path length 1.2 cm) using the DPC buffer solution 
above without protein as the reference solution.  The volume of sample per sector was 
120 µL.  The cells were loaded in a Beckman Ti-60 4-hole rotor.  Equilibrium absorbance 
measurements were taken at three speeds, and the data were analyzed by global 
nonlinear least squares fitting using the computer program “HeteroAnalysis Version 
1.1.0.44 - beta” (University of Connecticut) (27).  Cav1(62-178) was fit to the ideal model 
to obtain the weight-averaged molecular weight of the protein.  During fits, all 
parameters (molecular weight, baseline, and reference concentration) were allowed to 
float.  The partial specific volume of the protein (0.7603 mL/g) was calculated using 
established methodology (28).  The density of the buffer (1.0592 g/mL) was determined 
using a Kyoto Electronics Density/Specific Gravity Meter (model #DA-210).  Mutant 
Cav1(62-178)_P132L was fit to a monomer-nmer model (where n was fixed to a value of 
2).  During fits, all parameters (molecular weight, baseline, and reference concentration) 
were allowed to float.  The partial specific volumes of the proteins (0.7603 mL/g wild-
type, 0.7615 mL/g mutant) were calculated using established methodology (28).  The 
density of the buffer (1.0592 g/mL) was determined using a Kyoto Electronics 
Density/Specific Gravity Meter (model #DA-210).  
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RESULTS AND DISCUSSION 
 
 For studies of caveolin oligomerization we chose a construct that encompasses 
residues 62-178 (Cav1(62-178)).  In vivo studies have shown that when the first 65 
amino acids were deleted from caveolin-1, it had a behavior that was indistinguishable 
from that of the full-length protein (29).  This strongly indicates that Cav1(62-178) retains 
the crucial structural elements necessary for full caveolin-1 function. 
 Wild-type Cav1(62-178) was reconstituted into a buffer containing 
dodecylphosphocholine (DPC) micelles.  DPC micelles are a very native-like membrane 
mimic that is used widely in a variety of biophysical membrane protein studies (30, 31, 
32).  When the reconstituted protein was subjected to gel filtration analysis in the same 
buffer, a single symmetrical peak was observed (Figure 2 – solid line).  The presence of 
a single symmetrical peak indicates that a homogenous population of species is present, 
and that Cav1(62-178) is not forming multiple oligomeric states, which had been 
previously reported.  In addition, Cav1(62-178) did not elute in the void volume, 40 mL, 
revealing that caveolin-1 is not present in a high oligomeric state.  When the gel filtration 
column was calibrated with known globular protein standards, the Cav1(62-178) fraction 
had an apparent molecular weight of 115 kDa.  Based on these results, there is no 
evidence that caveolin-1 forms multiple oligomeric states which were reported 
previously.  Upon further examination, it is unclear whether the observed high-order 
oligomeric complexes in the previous study contained only the caveolin-1 protein and no 
other biomolecules such as cholesterol.  In fact, caveolin-1 has been described as a 
cholesterol binding protein (33).  Also, in the previous study, the presence of caveolin-1 
was the only protein that was probed for, so it is unclear whether other proteins may 
have been associated with these high molecular weight complexes as well. 
 Next, mutant Cav1(62-178)_P132L was subjected to gel filtration analysis.  The 
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mutant also elutes as a single, symmetrical, non-voided peak indicating that a 
homogenous population of species is present (Figure 2-1 – dashed line).  However, the 
mutant eluted before the wild-type, indicating that it was present as larger species.  In 
contrast to the wild-type, the mutant had an apparent molecular weight of 190 kDa.  
However, the gel filtration analysis does not give us definitive information about the 
oligomeric state of wild-type and mutant Cav1(62-178).  This is due to the fact that DPC 
molecules bound to Cav1(62-178) and the presence of a non-globular protein structure 
can dramatically inflate the apparent molecular weight. 
 To overcome the limitations of gel filtration analysis, wild-type and mutant Cav1(62-
178) were subjected to analysis by analytical ultracentrifugation.  The method of 
sedimentation equilibrium was employed because it is a very powerful approach for 
determining the molecular weight of proteins.  Importantly, sedimentation equilibrium 
experiments give molecular weight information that is independent of molecular shape.  
In addition, sedimentation equilibrium experiments can be run under density-matched 
conditions, which allows for the detergent contribution to the observed molecular weight 
to be eliminated (34, 35, 36).  Therefore, using this method, the exact oligomeric state of 
wild-type and mutant Cav1(62-178) can be characterized. 
 Figure 2-2 summarizes the data from the analytical ultracentrifugation experiments of 
both the wild-type and P132L mutant.  For wild-type Cav1(62-178) (Figure 2-2, A-C), the 
data were fit to the ideal species model.  This model gives a weight-averaged molecular 
weight of all species present.  However, it was clear from the gel filtration experiments 
that a homogenous population of species was present. After fitting, the observed 
molecular weight was determined to be 14,606 Da.  This agrees very well with the 
calculated molecular weight of the wild-type monomer which is 13,450 Da (The ~1 kDa 
discrepancy is most likely due to the inaccuracy of predicting partial specific volumes of 
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proteins in detergent solutions).  Based on these results it is clear that caveolin-1 is a 
monomer, and does not homo-oligomerize.  Importantly, this result helps to clarify the 
role of caveolin-1 in caveolae.  As stated previously, in vivo, caveolin-1 is isolated as a 
high molecular weight complex that is SDS resistant (16, 37).  However, it is unclear 
from this study as to whether caveolin-1 itself is responsible for the observed oligomeric 
behavior.  For example, caveolin-1 has been shown to closely associate with cholesterol 
in vivo; therefore the appearance of these high molecular weight complexes may be due 
to the presence of SDS resistant caveolin-cholesterol aggregates.  It is important to note 
that SDS is a much more powerful detergent towards protein deaggregation than DPC, 
which is much milder.  Considering this, it is highly unlikely that DPC would interfere with 
caveolin-1 oligomerization.  Additionally studies suggesting caveolin-1 oligomerizes have 
relied heavily on fragments of caveolin based on the N-terminal and scaffolding domains 
(16, 17, 29).  However, it is not clear from these studies whether the fragments were 
representative of the native caveolin-1 protein, and in one case the studies were 
performed in the absence of a membrane mimic which is not representative of caveolin-
1’s membrane environment.  Our studies reveal that when a fully-functional construct of 
Cav1(62-178) is analyzed in a membrane environment it does not form high-order 
oligomers and is in fact monomeric.   
 Next, mutant Cav1(62-178) was subjected to analysis by analytical 
ultracentrifugation (Figure 2-2, D-F).  Initially, the data were fitted to the ideal species 
model.  The resulting observed molecular weight was 28,282 Da.  This value is 
approximately twice the molecular weight of the P132L monomer, 13,465 Da, showing a 
dimeric species was forming.  Next, we explored the possibility of a monomer-dimer 
equilibrium by fitting the data to a monomer-dimer model.  After doing so, the resulting 
observed molecular weight of the monomer was 14,079 Da.  This corresponds very well 
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to the calculated molecular weight of the P132L monomer (13,465 Da).  In addition, the 
model yielded a dissociation constant of approximately 15 nM which shows that the 
dimer is remarkably stable.  From these results, we conclude that the P132L mutant is 
dimeric in a membrane-like environment unlike the wild-type which is monomeric. 
 After determining that the oligomeric state of P132L was dimeric, we turned our 
attention to determining the region of Cav1(62-178) P132L that was responsible for the 
observed dimerization.  Caveolin-1 is generally divided into 4 domains:  an N-terminal 
domain (residues 62-81), scaffolding domain (residues 82-95), transmembrane domain 
(residues 96-136), and C-terminal domain (residues 137-178). Therefore, truncated 
constructs of both wild-type and mutant caveolin-1 were generated:  residues 62-136, 
82-136, 82-178, 96-136, and 96-178.  Importantly, all constructs contained the intact 
transmembrane domain.  Each of the 5 constructs was run on gel filtration and the 
elution profiles of both wild-type and P132L were compared (Figure 2-3, B-F).  In all five 
cases, the P132L mutant elutes before the wild-type indicating that a larger species was 
forming.  Since all of the truncation constructs contained the intact transmembrane 
domain, these results indicated that the dimerization region is in the transmembrane 
domain of caveolin-1 where the P132L mutation is found. 
 Next, NMR structural studies were undertaken to observe the changes that were 
occurring in the transmembrane domain of wild-type versus mutant caveolin.  Figure 2-4 
shows an 15N-1H TROSY HSQC spectrum of mutant Cav1(96-136)_P132L.  Linewidths 
are larger when compared to the wild-type spectrum (Figure 2-5) indicating the presence 
of oligomers.  Chemical shift indexing (Figure 2-6) reveals that the transmembrane 
domain still retains the four distinct regions previously observed for the caveolin 
transmembrane domain:  There is an α-helix from residues 97-107 (helix 1), a break 
from residues 108-110, another α-helix from residues 111-129 (helix 2), and an 
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unstructured region from residues 130-136 (38).  Consistent with the horseshoe topology 
model of caveolin, the break at residues 108-110 is likely where the turn occurs so that 
the polypeptide chain can return to the membrane surface.  Clearly in the case of the 
mutant, the break is not being lost so it is unlikely that this mutant disrupts the proposed 
horseshoe topology.  In addition, helix 1 is unaffected as well.  However, helix 2 is 
extended 4 residues to encompass residues 111-133.  Therefore there is approximately 
one extra helical turn in the mutant.  The unstructured region now does not begin until 
residue 134.  This increased helicity is likely forming a dimerization domain in the 
transmembrane domain around position 132 (Figure 2-8).  In the native protein, P132 
acts to end the helix at residue 129 which prevents the dimerization from occurring.  
Therefore the helix-breaking tendency of proline is used to prevent the dimerization of 
caveolin. 
 Next, specific hydrophobic amino acid substitutions were made at position 132 to 
determine whether the other amino acids could substitute for proline at the 132 position.  
We chose to substitute the following residues: isoleucine, valine, alanine, glycine, 
tryptophan, and phenylalanine.  Each residue is non-polar so it should not affect the 
structure by limiting the integration into the micelle.  Each of these mutants were 
examined by gel filtration and compared to wild-type and mutant Cav1(62-178).  Based 
on the elution profiles of the mutants, we can see that all of them elute before the wild-
type (Figure 2-7) showing that all of the mutants retain dimerization capabilities.  
Retention times increased slightly from that of the P132L mutant indicating that the 
dimerization may be somewhat weaker for some of the mutants.  Clearly it appears that 
proline is the only amino acid that is tolerated at position 132 and it explains why this 
mutant is conserved in all of the three caveolin isoforms.   
 As stated in the Introduction, the mutation of P132L in caveolin-1 can result in a 
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variety of disease states.  However there has been little characterization of the 
differences between the wild-type and the mutant.  Importantly, our data show that wild-
type caveolin is monomeric and does not form high-order oligomers.  Therefore, the high 
order oligomers observed for caveolin are likely due to other proteins/factors that are 
present in vivo.  In contrast, the P132L mutant is a dimer.  This dimerization could 
explain why the mutant is retained in the Golgi apparatus and does not reach its final 
destination in the plasma membrane.  Furthermore, it is reasonable that other factors are 
responsible for the caveolin oligomers observed in vivo which would allow the cell to 
control when the oligomerization occurs.  For example caveolin could be transported to 
the plasma membrane as a monomer, and then once in place other factors such as 
cholesterol, or the protein PTRF/cavin could trigger the oligomerization.  Recent studies 
have shown that caveolin closely associates with the protein, PTRF/cavin.  In fact, when 
the PTRF/cavin gene is silenced, the number of caveolae in the plasma membrane 
diminishes (39).  The mutant, on the other hand, is a dimer which is not the proper 
oligomeric state for trafficking to the plasma membrane.  Proline is a very unique amino 
acid because it is conformationally rigid.  Because of this rigidity proline is known to be 
helix breaking.  This could be critical for caveolin as P132 is located towards the end of 
the transmembrane domain where the protein is transitioning from a near-vertical helix in 
the membrane to the C-terminal domain which is an amphipathic helix which is predicted 
to reside horizontally on the membrane surface.  When the proline is removed, the 
second helix of the transmembrane domain is extended by one turn.  This small change 
is significant enough to open up a dimerization domain in the helix (Figure 2-8).  No 
other non-polar amino acids can be substituted for proline, indicating how critical this 
residue is for caveolin structure.  Therefore, P132 is critical for proper caveolin-1 
structure and behavior. 
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CONCLUSIONS 
 
Caveolae are flask-like invaginations in the plasma membrane of cells that serve as 
signaling platforms.  The principle protein that is found in caveolae is caveolin.  Caveolin 
has three isoforms: 1, 2, and 3. Caveolin-1 is the most ubiquitous and it is necessary 
and sufficient to induce caveolae formation.  Caveolin-1 was thought to form high-order 
oligomers, which was believed to lead to the creation of caveolae (37).  A direct 
observation of caveolin-1 oligomerization has been lacking and most studies which set 
out to characterize caveolin-1 oligomerization were either biological in nature or they 
utilized small pieces of the protein in their studies to address this question.  The biology 
studies probed caveolae which were isolated from whole cell lysates for the presence of 
the caveolin-1 protein.  Caveolin was indeed found isolated to caveolae, but they were 
isolated in high molecular weight complexes.  The presence of other artifacts was not 
probed for in these complexes making it difficult to conclude that caveolin-1 forms high 
order oligomers.  Other studies which sought to measure caveolin-1 oligomerization 
directly used similar method, but they focused on evaluating small pieces of the 
caveolin-1 protein which may not accurately reflect the true behavior of the caveolin 
protein.  From the studies presented in Chapter 2 we can conclude that the protein is not 
oligomeric. These studies focus on using a construct of caveolin-1 that is fully functional 
and contains an intact intramembrane region of the protein.  Further, the oligomeric state 
of the P132L mutant of caveolin-1 is dimeric.  This contrast in the oligomeric states of 
the wild-type and mutant proteins may help to explain why the P132L protein does not 
traffic properly in vivo (21).  The nature of the P132L dimerization has not been fully 
elucidated; however, from these studies is appears that the intramembrane region may 
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be responsible for this interaction.  Further studies are necessary to uncover the 
chemical nature of the P132L dimerization. 
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Figure 2-1.  Elution profile of Cav1(62-178)_WT 
(solid black) and Cav1(62-178)_P132L 
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Figure 2-2.  Sedimentation equilibrium results of caveolin-1 in DPC micelles.  
Panels A-C represent Cav1(62-178)_WT at A) 30 µM B) 15 µM C) 7.5 µM and three 
speeds denoted in each panel.  Panels D-F represent Cav1(62-178)_P132L at A)30 
µM B) 15 µM C)7.5 µM and three speeds. 
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Figure 2-3.  Gel filtration chromatograms of caveolin-1 constructs.  A) Cav1(62-178) 
B) Cav1(82-178) C) Cav1(96-178) D) Cav1(62-136) E) Cav1(82-136) F) Cav1(96-
136).  The solid line represents wild type caveolin-1, the dashed line represents the 
P132L mutant. 
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Figure 2-4.  1H-15N TROSY HSQC spectrum of Cav1(96-136)_P132L.  
The spectrum was acquired with 256 complex points in t1 (15N) and 
2048 complex points in t2 (1H).  
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Figure 2-5.  Overlay of 1H-15N TROSY HSQC spectra of Cav1(96-
136)_WT (black) and Cav1(96-136)_P132L (red).  The P132L mutant 
displays a high degree of overlap with wild type caveolin-1 which shows 
that the mutant does not introduce global changes to caveolin-1.  Slight 
line broadening of the mutant can be seen indicating a small change in 
oligomeric state from the wild type. 
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Figure 2-6.  Chemical shift analysis of Cav1(96-136)_WT (black) and Cav1(96-
136)_P132L (red).  The P132L mutant shows an extension of helix 2 by four 
residues. 
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Figure 2-7.  Gel filtration chromatograms of Cav1(62-178)_P132X mutants. A) 
P132I B) P132G C)P132A D) P132F E)P132V F) P132W.  The solid line represents 
wild type caveolin-1, the dashed line represents each P132X mutant. 
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Chapter 3.  Evaluating Caveolin-1 Oligomerization in a Bilayer 
 
 
ABSTRACT 
 
 Caveolin-1 is the most important protein found in caveolae, which are 
invaginations of the plasma membrane.  It was once thought that caveolin-1 had the 
ability to form high-order oligomers which stabilizes the curvature of caveolae.  It was 
shown that in DPC micelles, caveolin is a monomer and does not have the ability to 
oligomerize by itself at all.  This result contradicts the initial belief that caveolin 
oligomerizes on its own thereby creating caveolae.  Although this was not observed in 
DPC micelles, it is important to consider the influence of a micelle environment on 
caveolin behavior.  To evaluate the oligomerization of caveolin in a true bilayer, bicelles 
were employed in the following study to determine if the oligomeric state of caveolin-1 
depends on the detergent / lipid environment.  Bicelles were first density matched using 
the density modifiers D2O, glycerol and sucrose.  D2O was chosen as the density 
modifier for subsequent caveolin-1 studies.  Cav1(62-178) was incorporated into bicelles 
using detergent dialysis to form DMPC vesicles from which bicelles were formed by 
subsequently adding the detergent, DHPC.  Results of the sedimentation equilibrium 
studies show that caveolin-1 remains monomeric in bicelles and its oligomeric state is 
not influenced by its lipid environment.    
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INTRODUCTION 
 The bicelle system has emerged as a lipid system in which to study membrane 
protein structure and protein interactions.  Bicelles are a better membrane mimic than 
micelles because they provide a true bilayer which reflects the natural protein 
environment in the cell.  Bicelles are comprised of two types of phospholipids, a long-
chain lipid and a short-chain lipid (Figure 1-3b).  When mixed together, the two lipids 
spontaneously organize in such a way that a discoidal-shaped aggregate assembles 
with the long-chain lipid comprising the planar region of the bicelle and the short-chain 
lipid assembles to form the rim of the bicelle.  Like, micelles, bicelles are also dynamic, 
therefore, they do not inhibit protein interactions.  Most commonly, dimyristoyl-3-
phosphatidylcholine (DMPC) is used as the long-chain lipid (Figure 1-3b) and 
dihexanoyl-3-phosphatidylcholine (DHPC) is used as the short-chain lipid (Figure 1-3b).  
However, bile salts such as CHAPSO can be used instead of the short-chain lipid.  The 
long chain lipid can vary in length, which effectively changes the thickness of the bilayer.  
The length of the bicelles can be tailored as well by changing the q value or the mole 
ratio of DMPC to DHPC.  Bicelles with a q of 0.5 and 1.0 were chosen for these studies 
because q = 0.5 bicelle have been well characterized and they support membrane 
protein structure and q = 1.0 bicelles provide an effective bilayer region in which to 
evaluate membrane proteins (1, 2, 3).  Bicelles have not yet been used in the analytical 
ultracentrifuge to evaluate the oligomeric properties of proteins.  The first step was to 
prepare bicelle solutions at varying densities in order to determine the density at which 
bicelles no longer sediment down a solution column, or where Meff = 0.  These studies 
also allow the density of q = 1.0 bicelles to be determined.  Three different density 
modifiers were used to adjust the density of the bicelle solutions: D2O, glycerol, and 
sucrose.  These density modifiers are biocompatible and do not substantially alter the 
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behavior of proteins and lipids in solution.  It was found that bicelles at a q=1.0 could be 
density matched using a D2O concentration of 74.5 % (v/v), a glycerol concentration of 
37.5 % (v/v), and sucrose concentration of 0.418 M.  The results of this study also show 
that the choice of density modifier has a small effect on the density of bicelles. 
 The results of the caveolin oligomerization studies carried out in DPC micelles 
reveal that caveolin is a monomer and does not have the ability to interact with itself.  
This begs the question, are micelles sufficient to support caveolin interactions?  Micelles 
have inherent limitations in that their extreme curvature may affect protein structure 
enough to influence the self-association of membrane proteins.  Also, micelles, while 
useful in the study of membrane proteins, do not provide a true bilayer environment 
where membrane proteins are natively found.  In order to understand if the micelle 
environment is influencing caveolin self-association it is necessary to study caveolin 
interactions in a bilayer environment.  Bicelles are well-suited to this goal because they 
are dynamic like micelles, which means they are equilibrium structures that will support 
the self-association of membrane proteins.  Also, bicelles provide a true bilayer 
environment where protein interactions can be more accurately assessed.  Lastly, 
bicelles have now been density matched using three different density modifiers; D2O, 
sucrose, and glycerol.  For these studies, D2O was chosen as the density modifier 
because it is most similar to water and it does not preferentially interact with bicelles in 
the way that sucrose and glycerol do.  The results of the study presented show that 
caveolin is also a monomer in bicelles, and further supports the use of bicelles as a 
medium in which to study membrane protein interactions. 
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MATERIALS AND METHODS 
Density matching bicelles 
 All sedimentation equilibrium density matching experiments were performed at 25°C 
using a Beckman XL-A analytical ultracentrifuge.  To 3.58 mg of lyophilized dimyristoyl-
3-glycero phosphatidylcholine (DMPC) containing a 1:10,000 ratio of DMPC to 1,2-
dimyristoyl-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (Avanti 
Polar Lipids, Alabaster, AL) 300 µL of buffer containing 10 mM HEPES, 100 mM NaCl 
pH 7.4 and various amounts of either D2O (0, 10, 25, 40, 50 , 60, 70, 80, 90 % (v/v)) , 
glycerol  (0, 2, 5, 10, 15, 20, 25, 30, 35 %(v/v)) or sucrose (0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 
0.7, 0.8 M) was added.  Next, the samples were vigorously vortexed until a 
homogeneous milk-like suspension was obtained. 13.03 µL of 25% (w/w) dihexanol-3-
glycero phosphatidylcholine (DHPC) solution was added to the DMPC to give a final 
DMPC : DHPC mole ratio of 1.0 (q = 1.0).  After adding the DHPC, the solution became 
clear.  The samples were loaded into a 6-sector charcoal filled epon centerpiece 
(pathlength 1.2 cm) using a reference solution that did not contain bicelles.  The volume 
of sample per sector was 120 µL, and the cells were loaded in a Beckman Ti-60 4-hole 
rotor.  Equilibrium absorbance measurments (468 nm) were taken at 10,000 rpm to 
35,000 rpm in 1,000 rpm increments.  Data was collected at each incremental speed.  
Initial equilibration was done at 10,000 rpm for 24 hours.  At each 1,000 rpm increment 
the equilibration time was 4 hours.  For each concentration of additive a plot of the 
natural log of the absorbance versus the square of the radius was generated.   This plot 
was fitted to a linear function and the buoyant molecular weight was extracted from the 
slope.  For each concentration the buoyant molecular weight was averaged over all 
speeds.  A total of nine data points were generated for each buffer additive (D2O, 
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glycerol, sucrose).  The density of the bicellar solutions were measured using a Kyoto 
Electronics Density/Specific Gravity Meter (model #DA-210).  
 
Incorporation of caveolin-1(62-178) into bicelles 
 
Caveolin was incorporated into bicelles using the detergent dialysis method 
presented in Mimms et al. (4).  0.25 mg of caveolin-1(62-178) was co-dissolved with 
5.96 mg of DMPC (1:500 protein:lipid mole ratio) in 500 µL of HFIP.  The sample was 
flash frozen in liquid nitrogen and lyophilized to a powder for a minimum of 16 hours.  
This lyophilized material was used to prepare 500 µL of a caveolin bicelle sample with a 
calculated absorbance of 1.0.  To the lyophilized lipid and protein, 440 µL of a 300 mM 
PFO, 10 mM Tris pH 8 solution is added.  This volume ensures a lipid concentration of 
20 mM, which is crucial to forming vesicles.  To the lyophilized powder 358.5 µL of D2O 
(density matched volume of 71.7%), 95.8 µL of water, 12.5 µL of 40X concentrated 
buffer (0.4 M HEPES, 4 M NaCl pH 7.4) and 21.7 µL of 25% DHPC (w/w) were added 
and the sample was left to mix on the rotating mixer until clear.  The sample was 
centrifuged at 15,000 x g for 2 hours and the presence or absence of a white pellet was 
monitored at the bottom of the tube.  The absence of a pellet confirms that most of the 
caveolin material has been incorporated into bicelles.  Next, an “empty bicelle” solution 
is prepared without caveolin.  To prepare 1.0 mL of a control or “empty bicelle” sample, 
11.92 mg of DMPC are weighed out in a 1.5 mL Eppendorf tube. 717.0 µL D2O is added 
to the DMPC powder in the tube followed by 25.0 µL of 40X concentrated HEPES; NaCl 
pH 7.4 buffer solution to give a final concentration of 10 mM HEPES, 100 mM NaCl pH 
7.4.  The DMPC was vortexed for several seconds to suspend the powder (17.6 mM 
final concentration) and 43.4 µL of a 25% (w/w) DHPC solution was added to a final 
concentration 24.4 mM.  The ratio of DMPC to DHPC yields an effective q-value of 1.0.  
The solution turns clear upon addition of the DHPC solution.  The empty bicelle solution 
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is used to prepare dilutions of the most concentrated caveolin-1(62-178) bicelle solution 
to give three protein concentrations, which represents the minimum data required to give 
an accurate estimate of the oligomeric state of caveolin. 
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RESULTS AND DISCUSSION 
The goal of this study was to evaluate the oligomeric state of caveolin-1 in a lipid 
bilayer medium.  Previous results in DPC micelles show that caveolin-1 (62-178) is 
monomeric, however, it is unclear if the extreme curvature of micelles is influencing the 
conformation and consequently biasing any preferential interactions of caveolin-1 with 
itself.  Membrane protein structure and function can be influenced by the lipid medium in 
which it resides, therefore, the goal of this study was to compare the oligomeric state of 
caveolin in micelles to the oligomeric state in a true bilayer environment.  Bicelles were 
chosen as the medium in these studies primarily because they are well-characterized, 
dynamic system.  They are equilibrium structures as well, which makes them conducive 
to sedimentation equilibrium studies in the analytical ultracentrifuge as well.  Bicelles 
with a q = 1.0 were chosen for the caveolin studies because they were best suited to the 
incorporation of caveolin-1 (62-178) and they provide a larger bilayer area in which 
oligomerization can be better evaluated. 
 
Choice of Caveolin-1 Construct 
 For these studies a construct of caveolin-1 was chosen that encompasses residues 
62-178.  This construct contains the intact intramembrane region of caveolin (96-136).  
In vivo studies have shown that when the first 65 amino acids were deleted from the 
caveolin-1, it had a behavior that was indistinguishable from that of the full-length protein 
(5).  This strongly indicates that Cav1(62-178) retains the crucial structural elements 
necessary for full caveolin-1 function, specifically, the full transmembrane region 
(approximately 96-136).   
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Density Matching Experiments 
 To characterize the precise oligomeric state of caveolin, we used sedimentation 
equilibrium analytical ultracentrifugation.  The method of sedimentation equilibrium was 
employed because it is a very powerful approach for determining the precise molecular 
weight of Cav1(62-178), in the presence of bicelles.  To determine the molecular weight 
of Cav1(62-178) it is necessary to subtract out the molecular weight of the bicelles first.  
The method of density matching was employed to accomplish this task.  Density 
matching is often used in membrane protein experiments where detergents and lipids 
are present, and this approach allows us to eliminate the molecular weight contribution 
of the detergent to the molecular weight of the protein (6, 7, 8).  Density matching of the 
bicelles was carried out using D2O, sucrose and glycerol, which are three commonly 
used density additives that are compatible with proteins and do not cause them to 
denature.  Bicelles with a q = 1.0 have not been density-matched in the analytical 
ultracentrifuge.  By adapting the method of sedimentation equilibrium to bicelles a more 
accurate depiction of membrane protein interactions can be evaluated since bicelles 
provide a true bilayer environment.  Cav1(62-178) oligomerization was also assessed in 
bicelles using sedimentation equilibrium.  A total of nine bicelle solutions were prepared 
for each of the three density- matching experiments using the different density modifiers.  
The number of bicelle samples is consistent with the maximum number of samples that 
can be run in a 4-hole rotor at one time.  The density of each of the prepared bicelle 
solutions was measured using a density meter and summarized in Table 3.1.  Each of 
the bicelle solutions was subjected to sedimentation equilibrium analysis and the data 
were treated with the Lamm equation.  From the Lamm equation, the effective molecular 
weight of the bicelles in each of the nine solutions was determined.  A plot of the 
effective molecular weight of the bicelle solutions versus the buffer density was 
 63 
generated for each density modifier as shown in Figures 3-1, 3-2, 3-3.  From these 
results, we determined the point at which the effective molecular weight of the bicelles is 
zero for each additive, thereby establishing the density matched concentration of each 
additive required (Figure 3-4).  The results are summarized in Table 3.2 where we can 
see that the partial specific volume of the bicelles is dependent on the density modifier 
used.  For example, in D2O, the bicelles have a partial specific volume of 0.923 mL / g 
versus 0.943 mL / g in sucrose.  This suggests that the lipids in the D2O bicelles may be 
packed more closely compared to the lipids in bicelles prepared with sucrose.  This data 
represents, to our knowledge, the first instance where q = 1.0 bicelles have been 
successfully density-matched and their partial specific volume determined.   
 
Caveolin-1 Incorporation into Bicelles 
 Several approaches were investigated to incorporate Cav1(62-178) into q = 1.0 
bicelles.  The method that was most effective was detergent dialysis. Cav1(62-178) has 
a strong tendency to irreversibly aggregate; therefore, it was necessary to ensure that 
Cav1(62-178) was monomeric prior to dialyzing into DMPC bilayers to form vesicles.  
Previous experiments show that Cav1(62-178) is monomeric in DPC micelles.  DPC was 
chosen initially as the detergent from which to dialyze; however due to the low critical 
micelle concentration (CMC) DPC proved to be particularly challenging to remove 
completely by dialysis and consistent results were difficult to produce.  The fluorinated 
detergent, PFOA, was superior to most detergents because it was powerful enough to 
solubilize Cav1(62-178) and DMPC, and it dialyzed more efficiently.  It also provided 
more reproducible dialysis results compared to DPC.  The temperature of the dialysis is 
an important factor and is critical to the quality of Cav1(62-178) bicelles that are formed.  
PFOA does not dialyze efficiently at temperatures below 21 °C, yet lower temperatures 
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are effective at preventing undesirable Cav1(62-178) aggregation.  The best results 
were obtained when the temperature was held constant during dialysis by incubating at 
21 °C.                 
 
Caveolin-1 Oligomerization in Bicelles 
 The sedimentation profile of Cav1(62-178) was obtained at three different speeds 
and using “Heteroanalysis Version 1.1.0.44 - beta”, the data were fit globally to a single 
species model.  This model provides an average molecular weight of all oligomeric 
populations present in solution.  However, based on the gel filtration analysis, it is clear 
that caveolin-1 only exists in one oligomeric state.  Figure 3-6 shows the fitted data from 
the analytical ultracentrifugation experiments of Cav1(62-178) in q = 1.0 bicelles.  
Cav1(62-178)
 
was analyzed at concentrations of 30 µM, 15 µM, and 7.5 µM at 25,000, 
30,000, and 35,000 rpm.  After fitting the sedimentation equilibrium data to the single 
species model, the observed molecular weight was determined to be 14,650 Da.  This 
agrees very well with the calculated molecular weight of the caveolin-1 monomer which 
is 13,450 Da (calculated from the amino acid sequence). The ~1 kDa discrepancy can 
be attributed to the inherent error of predicting the partial specific volume of membrane 
proteins in detergent solutions (9).  From this data it is clear that when a fully-functional 
construct of Cav1(62-178) is analyzed in a membrane environment it does not form high-
order oligomers, but instead is monomeric.  These results are similar to the results 
obtained for the investigation of caveolin in DPC micelles.  This indicates that DPC is not 
responsible for the observed monomeric state of caveolin in previous studies. 
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CONCLUSIONS 
 There has been skepticism surrounding the hypothesis that caveolin-1 has the 
ability to form high-order oligomers, which drives and/or stabilizes the caveolae 
invaginations on the surface of the plasma membrane in mammalian cells.  This study 
set out to address the question, does caveolin-1 have the ability to form high-order 
oligomers on its own or could there be other biomolecules involved in the creation of the 
observed high-order complexes that were previously characterized by SDS-PAGE.  A 
previous study presented in this thesis shows that in DPC micelles, caveolin-1 is 
monomeric while a naturally occurring mutant, P132L is dimeric.  This study provides 
evidence that even in a bilayer, which is more native-like than a micelle, caveolin-1 is still 
monomeric and does not oligomerize.  For the first time, we also show that q = 1.0 
bicelles can be successfully density matched, and this medium is conducive to studies of 
membrane protein interactions in the analytical ultracentrifuge. Bicelles are ideal for 
studying membrane protein interactions compared to micelles because the extreme 
curvature introduced by the latter can bias protein conformation resulting in changes in 
protein behavior.     
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Sample 
# 1 2 3 4 5 6 7 8 9 
D
2
O 
0% 10% 25% 40% 50% 60% 70% 80% 90% 
1.0060 1.0169 1.0332 1.0495 1.0604 1.0713 1.0822 1.0931 1.1039 
glycerol 
0% 2% 5% 10% 15% 20% 25% 30% 35% 
1.0056 1.0114 1.0201 1.0346 1.0490 1.0635 1.0780 1.0925 1.1070 
sucrose 
0 M 0.1 M 0.2 M 0.3 M 0.4 M 0.5 M 0.6 M 0.7 M 0.8 M 
1.0059 1.0192 1.0325 1.0458 1.0590 1.0723 1.0856 1.0990 1.1122 
Table 3.1.  Density measurements of bicelle solutions with density modifiers 
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Density Modifier Partial specific volume (mL / g) % (v/v) or Molarity 
Buffer Density              
( g / cm3) 
D2O 0.923 71.7 1.084 
Glycerol 0.932 23.4 1.073 
Sucrose 0.942 0.418 1.061 
 
  
Table 3.2.  Partial specific volume of q = 1.0 bicelles determined from density 
matching experiments 
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Figure 3-1.  Ln (c) versus radius2 of bicelle solutions with varying 
concentrations of D2O.  Concentrations of D2O are expressed in % v/v and are 
denoted in each of the figure panels.  The slope of the lines represents Meff at 
different concentrations of D2O.  A slope of zero represents the point at which 
Meff = 0 and the bicelles are matched, approximately 70% (v/v) D2O. 
. 
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Figure 3-2. Ln (c) versus radius2 of bicelle solutions with varying 
concentrations of glycerol.  Concentrations of glycerol are expressed in % v/v 
and are denoted in each of the figure panels.  The slope of the lines 
represents Meff at different concentrations of glycerol.  A slope of zero 
represents the point at which Meff = 0 and the bicelles are matched, 
approximately 23.4% (v/v) glycerol. 
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Figure 3-3.  Ln (c) versus radius2 of bicelle solutions with varying concentrations 
of sucrose.  Concentrations of sucrose are expressed in Molarity and are 
denoted in each of the figure panels.  The slope of the lines represents Meff at 
different concentrations of D2O.  A slope of zero represents the point at which 
Meff = 0 and the bicelles are matched, approximately 0.5 M sucrose. 
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Figure 3-4.  Meff versus buffer density.  The dotted line indicates the point at 
which Meff of bicelles equals zero, which corresponds to a specific buffer 
density for each different density modifier tested.  The buffer density required 
to density match bicelles is slightly dependent on the density modifier used in 
each experiment indicating a small, but noticeable change in the partial 
specific volume of bicelles for each density modifier used.  a) D2O b) glycerol 
c) sucrose  
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Figure 3-5.  Sedimentation equilibrium data of caveolin-1 (62-178) in q = 1.0 
bicelles at three different speeds and concentrations.  The different speeds 
are highlighted in colors.  Red represents the data collected at 15,000 rpm, 
blue represents the data collected at 25,000 rpm, and green represents the 
data collected at 35,000 rpm.  a) 30 µM protein concentration b) 15 µM protein 
concentration c) 7.5 µM protein concentration. 
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Chapter 4. Investigating LMPG and LMPC micelles for the study 
of membrane protein interactions in the AUC 
 
 
ABSTRACT 
 
 It is often useful to employ several techniques to study membrane protein 
structure and function.  For example, in studies of the caveolin-1 protein information can 
be gleaned from both NMR and analytical ultracentrifuge analysis.  However, the 
detergents used in each of these studies were not the same because it is difficult to 
obtain highly resolved structural data in DPC micelles.  On the other hand, DPC micelles 
have been used successfully in AUC studies to characterize the oligomeric state of 
caveolin-1 and a P132L mutant (Chapter 2).  NMR analysis of the P132L mutant showed 
a possible explanation for the dimerization of mutant caveolin-1, but these studies were 
carried out in different detergents which is not ideal when drawing conclusions about 
membrane protein structure and function.  The detergent, LMPG, has proven useful in 
acquiring structural data of the intramembrane region of caveolin-1, but LMPG has not 
been density matched or used in studies of membrane protein oligomerization.  The goal 
of this study was to determine if LMPG micelles can be density matched in the AUC so 
that the oligomerization of caveolin-1 can be investigated in LMPG and compared to 
structural NMR studies.  LMPG micelles are very dense and were not able to be density 
matched using D2O or 100 % D2O18.  The detergent, LMPC, was also investigated to 
determine if a mixed micelle system of LMPG and LMPC could be density matched and 
translated to structural NMR studies.  Although LMPC and LMPG mixed micelles looked 
promising for AUC studies, structural NMR data of caveolin-1(96-136) showed that only 
a small amount of LMPC (25 mM) was tolerated before the resolution collapsed.  At 25 
mM; however, LMPC / LMPG micelles are still too dense to be matched in the AUC.           
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INTRODUCTION 
 Although detergent and lipid molecules have the same general properties in that 
they are amphipathic, they also vary in their ability to solubilize and preserve native 
protein structure.  For this reason, it is difficult to find a universal detergent or lipid 
system that is optimal to study membrane protein structure and behavior.  Often times a 
rigorous screening is required to find the appropriate detergent or lipid for each 
application.  Not only does the choice of detergent or lipid depend on the protein being 
studied, it also depends on the analytical method that is employed because not all 
detergents and lipids are conducive to all analytical methods.  For example, 
dodecylphosphocholine (DPC) is a very native-like detergent that is often used in the 
study of membrane proteins (1).  Specifically, DPC has allowed the oligomeric state of 
caveolin to be characterized in the AUC.  However, this detergent is not always 
conducive to structural studies using solution NMR.  For example, caveolin-1 is soluble 
in DPC micelles, but it does not allow useful NMR data to be obtained.  The chemical 
shifts of most amino acid residues are not able to be resolved using this detergent.  The 
lipid, LMPG, has been particularly useful in acquiring interpretable NMR data.  In order 
to compare structural studies of caveolin with oligomeric studies obtained from AUC 
experiments, it is best if this can be accomplished using the same detergent or lipid 
system.  Studies of membrane protein oligomerization have not been accomplished 
using LMPG in the AUC; therefore, in this chapter the utility of LMPG as a lipid system in 
which to study membrane protein interactions in the AUC will be explored.  In order to 
begin these studies, it is necessary to density match LMPG micelles using the same 
approach that was used to density match bicelles (Chapter 3) where the density of 
LMPG micelles will first be determined.  Subsequently, the LMPG micelles will be 
subjected to sedimentation equilibrium studies using varying amounts of a density 
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modifier present in the sample.  The density of the LMPG micelles at each concentration 
of density modifier will be graphed versus the measured buffer density to determine the 
amount of density modifier required for the effective molecular weight of the micelles to 
be zero.  Once the density matched conditions for LMPG have been established, 
caveolin-1(62-178) will be incorporated into LMPG micelles and the molecular weight will 
be evaluated in order to compare the oligomeric state of caveolin-1 in LMPG micelles 
versus DPC micelles.  This study will reveal any dependence of the observed oligomeric 
state of caveolin on the detergent or lipid system used in our studies.  It will further 
reveal any dependence of caveolin oligomerization on the lipid environment in which it 
resides.  
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MATERIALS AND METHODS 
 
Measuring the density of LMPG and LMPC lipid solutions 
 
Solutions of LMPG were prepared separately at different concentrations in a 
buffer containing 10 mM HEPES, 100 mM NaCl pH 7.5:  400 mM, 350 mM, 300 mM, 
250 mM, 200 mM, 175 mM, 150 mM, 100 mM, 50 mM, 20 mM, 0 mM.  The final volume 
prepared for each solution was 1.8 mL which is the minimum volume required to fill the 
sample loop of the density meter.  Due to the extensive amount of lipid required for 
these measurements the 400 mM LMPG solution was diluted for each subsequent 
measurement down to 10 mM LMPG.  The density measurements of each sample were 
obtained using a Kyoto Electronics Density/Specific Gravity Meter (model #DA-210).  
 
Preparation of LMPG samples for analytical ultracentrifugation  
 A solution of 0.5 mg / mL diphenylhexatriene (DPH) was prepared in toluene.  In 
a separate eppendorf tube a 100 mg / mL solution of LMPG in HFIP was prepared.  To 
each of nine eppendorf tubes, 2.39 mg of LMPG (23.9 µL) was added followed by 2 µL 
(2 µg) of DPH solution.  The amount of DPH was determined by calculating the desired 
molarity based on a target absorbance of 0.5, the extinction coefficient of DPH (88,000 
M-1cm-1), path length of 1.2 cm, and sample volume of 100 µL.  The samples were 
frozen and lyophilized overnight to create a homogeneous mixture of lipid and DPH.  
Water was added to each sample (500µL) in order to facilitate freezing and 
lyophilization. 
 The lyophilized samples were rehydrated in 100 µL of 10 mM HEPES; 100 mM 
NaCl pH 7.4 buffer with gentle heating (42 °C water  bath) and vortexing until the 
samples were clear.  Samples were loaded into sedimentation equilibrium 6-channel 
epoxy coated centerpiece and spun at increments of 1000 rpm beginning at 10,000 rpm 
 78 
and increasing to 40,000 rpm.  Samples were left to equilibrate at 10,000 rpm for 20 
hours before measuring the absorbance profile and 4 hours thereafter at each 
subsequent speed before measuring the absorbance.  The data were treated with the 
Lamm equation and Meff was measured from the slope of the ln(c) vs. the square of the 
radius from the center of rotation: 
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Preparation of caveolin-1(96-136) NMR samples in LMPG / LMPC lipid mixtures 
 Uniformly 15N-labeled Cav1(96-178) was prepared by overexpressing in E. coli 
grown in auto-induction media supplemented with 15NH4Cl salt according to the method 
of Lee et al. (Appendix II – N-5052 Media) (5).   Lyophilized caveolin-1(96-136) protein 
was reconstituted into three different solutions containing varying ratios of LMPG and 
LMPC but not exceeding a total lipid concentration of 100 mM: 1) 100 mM LMPG, 2) 75 
mM LMPG / 25 mM LMPC, 3) 50 mM LMPG / 50 mM LMPC, 4) 25 mM LMPG / 75 mM 
LMPC, 5) 100 mM LMPC.  The caveolin-1(96-136) protein-lipid solutions were buffered 
with 20 mM phosphate, 150 mM NaCl pH 7.5 containing 10% D2O (v/v).   The solutions 
were vortexed vigorously for several minutes, immersed in a hot water bath (95 °C) for 
one minute, and centrifuged for 10 minutes at 20,000 x g at room temperature.  A clear 
solution was obtained with no visible precipitate.   
 NMR data was acquired at 25 °C on a 600 MHz  Bruke r Advance II spectrometer 
(Billerica, MA) equipped with a cryoprobe.  TROSY-HSQC data was obtained for 15N-
labeled Cav1(96-136) in different LMPG / LMPC solutions.  The spectra were processed 
using NMRPipe and Sparky (2, 3).    
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RESULTS AND DISCUSSION 
 
 The density of LMPG was determined by measuring solutions of LMPG that were 
prepared in a 10 mM HEPES; 100 mM NaCl buffered solution at pH 7.4.  The results of 
the LMPG density measurements are summarized in Table 4.1.  Densities were plotted 
against the concentration of each LMPG solution in order to determine the slope of the 
linear relationship between lipid concentration and density (Figure 4-1).  From these 
results the density of the LMPG lipid can be calculated based on the method of 
Durchschlag (4). 
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From this equation, the density of LMPG was calculated to be 1.21 g / mL.  This density 
is significantly higher than water (1.0 g / mL) and requires a large quantity of a density 
modifier present in the sample to be matched.  Based on the density matching study of 
bicelles in Chapter 3 a 1.08 g / mL density is required to match the density of q = 1.0 
bicelles.  This corresponds to 71.7% D2O required in the sample.  Using the program, 
Sednterp, version 1.0, U. of New Hampshire, to calculate the density of a 100% D2O 
solution buffered with 10 mM HEPES, 100 mM NaCl pH 7.4, it was found that the 
density of 100% D2O is 1.107 g / mL.  This density is not high enough to match LMPG 
micelles based on the calculated density.  As an alternative, D2O18 was investigated as a 
density modifier as well.  Using Sednterp, version 1.0, U. of New Hampshire to calculate 
the density of 100% D2O18 it was found to be 1.21623 g / mL, which is suitable to 
completely match the density of LMPG micelles.   
Sedimentation equilibrium (AUC) experiments were carried out to experimentally 
determine the partial specific volume of LMPG micelles.  50 µL samples containing 50 
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mM LMPG doped with DPH at a ratio of 1:10,500 (DPH : LMPG) were initially spun at 
10,000 rpm (8050 x g) for 16 hours until equilibrium was reached.  The LMPG micelles 
were measured at a wavelength of 352 nm, which corresponds to the ʎmax absorbance 
of DPH.  After spinning for 16 hours at 10,000 rpm, the speed was increased by 1000 
rpm, the samples were left to equilibrate for 6 hours (determined empirically) and the 
absorbance profiles were recorded.  The speed of the analytical ultracentrifuge was 
increased to a maximum of 40,000 x g.  The Meff of each sample was calculated using 
the Lamm equation (Materials and Methods) to determine the concentration of D2O18 
required for Meff = 0 for LMPG micelles.  Preliminary results show that at all 
concentrations of D2O18 that were sampled in the AUC, LMPG was more dense than the 
buffer (Figure 4-2).  By extrapolating the Meff data we can see that the amount of D2O18 
required to achieve Meff of zero for LMPG is 103% (v/v).  Therefore, it is not possible to 
completely density match LMPG micelles using heavy water.  It is clear from the 
sedimentation equilibrium experiments that LMPG creates very dense lipid micelles 
making it difficult to adapt to sedimentation equilibrium experiments.  However, it may be 
possible to mix LMPG with a similar lipid such as LMPC in order to attenuate the density 
of the LMPG.  LMPC has the same lipid chain length as LMPG and a choline head group 
instead of the glycerol head group of LMPG.  LMPC has also been used successfully in 
NMR to obtain structural information about membrane proteins.  The density of this lipid 
was also measured at various concentrations of LMPC, and the data were tabulated 
(Table 4.2) and plotted against lipid concentration (Figure 4-3).  By treating the slope of 
the line in Figure 4-3 with the Durchschlag equation the density of LMPC was calculated 
to be 1.086 g / mL, which still exceeds the density of 100% D2O, but does not exceed 
the density of D2O18 (1.25 g / mL).  A 50 / 50 mixture of the two lipids reveals that the 
density of the mixed lipid solutions is lower than the LMPG solutions, which indicates 
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that a mixture of these two lipids may be more amenable to sedimentation equilibrium 
studies (Table 4.3).  The density data for the lipid mixture was also plotted as a function 
of total lipid concentration in order to quantitate the density of the 50 / 50 LMPG / LMPC 
mixture (Figure 4-4).  The density was calculated to be 1.15 g / mL, which is 
approximately equivalent to the average of the densities of LMPG and LMPC.  The 
minimum amount of LMPG required to achieve a target density of 1.15 g / mL in a 
mixture of both lipids was calculated to be 37.5 % (w/w).  The calculated value differs 
slightly from the density that was measured for the 50 / 50 mixtures of the two lipids.  
However, it is clear that at least 50% LMPC lipid is required to lower the density to where 
sedimentation equilibrium can be carried out.   
LMPG is a powerful lipid that has been used with success to obtain structural 
information about the caveolin-1 protein (5).  Few lipids are able to provide such 
valuable information about caveolin structure.  The goal of these experiments was to 
adapt LMPG to sedimentation equilibrium studies in the AUC so that both structural and 
behavioral information can be obtained for caveolin using the same lipid system.  
Membrane protein structure and function can be influenced by the lipid medium in which 
it resides, therefore, it is ideal to study caveolin in the same lipid system.  In order to 
proceed using a mixture of LMPG and LMPC, it is important to evaluate the ability of this 
lipid mixture to support caveolin-1 structure, which can be determined using solution 
NMR.  To evaluate the utility of the LMPG / LMPC lipid mixture, the intramembrane 
region of caveolin-1 (96-136) was labeled with 15N and reconstituted into mixtures of 
LMPG / LMPC.  HSQC spectra were obtained for each sample and compared to the 
structure of caveolin-1(96-136) in 100% LMPG.  We can see from Figures 4-5, 4-6, 4-7, 
4-8, and 4-9 that as LMPC is added to the samples, the resolution of the peaks begins to 
diminish.  This indicates that LMPC does not have the ability to provide clearly resolved 
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structural data compared to LMPG.  The presence of LMPC is tolerated up to a 
concentration of 25 mM (Figure 4-6), which shows that most of the signals from each 
residue are clearly resolved and well-dispersed in the spectrum.  However, at 50 mM 
LMPC the peaks begin to collapse and overlap significantly, which indicates that this 
lipid mixture is not suitable to acquire structural data.  From the sedimentation 
equilibrium studies and the density meter studies we know that a minimum of 50 mM 
LMPC is desirable for density matching to be achieved, but if the presence of LMPC 
cannot support caveolin structure then it is not possible to use this lipid system to 
evaluate oligomerization in the analytical ultracentrifuge. 
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CONCLUSIONS 
 LMPG is an anionic detergent phospholipid that has been used successfully to 
solve membrane protein structure using solution NMR.  It has been used to elucidate 
important structural information about the integral membrane protein, caveolin-1.  Aside 
from structural information we wanted to probe the utility of LMPG in evaluating protein 
interactions in the analytical ultracentrifuge.  By using the same lipid in which to evaluate 
membrane protein structure and function we can better compare this data in order to 
learn how this protein is able to curve the plasma membrane in vivo.  The lipid system in 
which membrane proteins are studied can have a significant effect on their structure and 
function.  Therefore, it is desirable to use the same lipid in multiple studies.  In this study 
we attempted to adapt LMPG to sedimentation equilibrium experiments in the AUC.  
LMPG is a very dense lipid and alone cannot be density matched.  However, LMPC is a 
similar lipid that has been used with some success in membrane protein NMR studies.  It 
has a significantly lower density than LMPG and we show that a 50 / 50 mixture of the 
two lipids has a density closer to 1.0 g /mL, which is more conducive to density 
matching.  HSQC NMR data of caveolin-1(96-136) in LMPG / LMPC mixtures shows that 
LMPC is not amenable to NMR studies of caveolin because the signals from the amino 
acid residues collapse in the presence of LMPC. The collapse of the HSQC NMR signal 
from caveolin intramembrane domain residues may be due to two reasons: LMPC 
creates a highly dynamic environment for protein structure causing peak broadening, or 
LMPC is zwitterionic and the lack of net charge (like LMPG) may not be strong enough 
to prevent caveolin from aggregating.  Although LMPC can be density matched in the 
AUC, it is not suitable for NMR studies of caveolin, therefore, it offers no advantages 
over other detergents such as DPC, which has been both successfully density matched 
and used to obtain oligomeric information about membrane proteins. 
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LMPG concentration (mM) Density (mL) LMPG concentration (mg / mL)
400. 1.03122 191.4
350. 1.02748 167.5
300. 1.02367 143.6
250. 1.01996 119.6
200. 1.01616 95.7
175 1.01425 83.7
150. 1.01205 71.8
100. 1.00848 47.9
50.0 1.00470 23.9
20.0 1.00239 9.57
0.00 1.00044 0.00
Table 4.1.  Density measurements of LMPG solutions. 
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LMPC concentration (mM) Density (mL) LMPC concentration (mg / mL)
400. 1.01507 187.0
350. 1.01422 164.0
300. 1.01233 141.0
250. 1.01045 117.0
200. 1.00856 93.5
175 1.00761 82.0
150. 1.00662 70.0
100. 1.00455 46.8
50.0 1.00275 23.4
20.0 1.00161 9.35
0.00 1.00074 0.00
Table 4.2.  Density measurements of LMPC solutions 
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Figure 4-1. Measured LMPG density versus LMPG 
concentration plotted from Table 4.1. The slope of the line is 
used to determine the partial specific volume of LMPG micelles, 
which was found to be 0.83989 cm3 / g using the Durchschlag 
equation.  
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Figure 4-2. Meff determination of LMPG micelles at 
various D2O18 concentrations.  LMPG micelles are not 
able to be density matched using D2O18.  Using the 
equation of the line, the amount of D2O18 required to 
reach Meff = 0 is 103% (v/v). 
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Figure 4-3. Measured LMPC density versus LMPC 
concentration plotted from Table 4.2.  The slope of the line is 
used to determine the partial specific volume of LMPC micelles, 
which was found to be 0.92004 cm3 / g using the Durchschlag 
equation.  
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LMPC concentration (mM) LMPG concentration (mM) Density ( g /mL)
200. 0.00 1.00856
140. 60.0 1.01465
100. 100. 1.01547
40.0 160. 1.01740
0.00 200. 1.01661
0.00 0.00 0.99990
Table 4.3.  Density measurements of LMPC and LMPG mixtures. 
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Figure 4-4. Density measurements of 50 / 50 LMPG / LMPC 
solutions versus total lipid concentration.  The slope of this line 
was used to determine the partial specific volume of a 50/50 
LMPG / LMPC micelle mixture, which was found to be 0.87020 
cm3 / g or 1.15 g / cm3 using the Durchschlag equation.  
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Figure 4-5. 1H-15N HSQC spectrum of Cav1(96-136) in 100 mM LMPG.  
The signals from all amino acid residues are resolved and peaks are well-
dispersed. 
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Figure 4-6. 1H-15N HSQC spectrum of Cav1(96-136) in 75 mM LMPG, 25 
mM LMPC.  The signals from most amino acid residues are resolved and 
they are still relatively well-dispersed.   
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Figure 4-7. 1H-15N HSQC spectrum of Cav1(96-136) in 50 mM LMPG, 50 
mM LMPC.  Signals from amino acid residues have disappeared and there 
is significant peak broadening.  The signal is no longer well-dispersed. 
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Figure 4-8. 1H-15N HSQC spectrum of Cav1(96-136) in 25 mM LMPG, 75 
mM LMPC.  Signals from amino acid residues have disappeared and 
there is significant peak broadening.  The signal is no longer well-
dispersed. 
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Figure 4-9. 1H-15N HSQC spectrum of Cav1(96-136) in 100 mM LMPC.  
Signals from amino acid residues have disappeared and there is significant 
peak broadening.  The signal is no longer well-dispersed. 
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Chapter 5. Investigation of C8E5 / DMPC Lipid Aggregates   
 
 
ABSTRACT 
 
 Lipids and detergents can have a significant impact on membrane protein 
structure and function. When studying membrane protein oligomerization it is important 
to consider the lipid or detergent system in which these studies are carried out. Bicelles 
are unique in that they provide a lipid bilayer region that can support membrane protein 
structure and function.  Also, bicelles are dynamic and allow proteins and other 
molecules to freely associate and dissociate.  In traditional bicelles the two most 
commonly used phospholipids are DMPC, used as the long-chain lipid, and DHPC, used 
as the short-chain lipid.  These bicelles were previously density matched in the analytical 
ultracentrifuge using 71.7% D2O so that caveolin oligomerization could be carried out.  
The bicelles proved to be a very valuable tool in caveolin oligomerization experiments, 
but with 71.7% D2O present in the sample, meaningful data could only be achieved at 
exceptionally high speeds (above 50,000 x g).  The goal of this study was to investigate 
a new lipid aggregate system where pentaethylene glycol monooctyl ether (C8E5) was 
used as the short-chain, rim-capping detergent instead of DHPC.  C8E5 has a density of 
1.007 g /cm3 making it very similar to water.  This is expected to lower the density of 
DMPC / C8E5 lipid aggregates such that they will not require density matching or the 
use of a density modifier.  By avoiding the use of density modifiers like D2O, higher 
speeds will not have to be sampled in order to sediment proteins in oligomerization 
studies. 
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INTRODUCTION 
 In the study of membrane protein interactions many detergents and lipids that are 
effective at solubilizing membrane proteins are not always conducive to biophysical 
studies.  In analytical ultracentrifugation it is often necessary to perform a technique 
called density matching to subtract out the molecular weight contribution of the 
surrounding lipids when investigating the oligomeric state of membrane proteins.  This 
technique is necessary to avoid inflating the calculated molecular weight of the 
sedimenting species when the lipid and / or detergent is more dense than the buffer.  
Micellar systems have been density matched in the past and used successfully to 
assess membrane protein oligomerization.  More recently, this technique has been used 
to density match bicelles (Chapter 3); however, the high levels of density modifier 
required (e.g. 71.7 % D2O) can be problematic.  When attempting to study low molecular 
weight peptides and proteins high speeds are required to sediment these species.  
When high amounts of density modifier are present it can be difficult to achieve the 
speeds necessary to sediment small peptides or proteins.  DMPC and C8E5 both have 
densities that are similar to water, 1.0381 g / cm3 and 1.0071, respectively (1, 2).  
Therefore, it may not be necessary to density match these detergents when using them 
to study membrane protein interactions in the analytical ultracentrifuge.  It is unclear 
whether mixtures of DMPC / C8E5 form a mixed micelle system or a bicelle system like 
the DMPC / DHPC system.  We hypothesize that the C8E5 / DMPC lipid / detergent 
system forms a bicellar lipid / detergent aggregate similar to the DMPC / DHPC system 
previously observed.  To answer this question, 31P-phosphorus NMR experiments were 
carried out to compare the chemical shift of DMPC in both a DMPC / DHPC bicelle 
sample and a DMPC / C8E5 sample.  Lipids that are organized heterogeneously as in 
the case of the DMPC / DHPC bicelle system experience different lipid environments 
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giving rise to two distinct chemical shifts in the NMR arising from the phosphorous 
headgroup on the short-chain lipid (DHPC) versus the phosphorus group on the long-
chain lipid (DMPC).  The presence of two distinct environments is indicative of a 
heterogenouse bicelle-like organization of the lipids.  Although, C8E5 does not contain a 
phosphorus headgroup, the chemical shift of DMPC in the C8E5 / DMPC sample is 
expected to produce a similar chemical shift to that of the DMPC / DHPC sample if it is 
experiencing a bicelle-like environment.  A lanthanide shift reagent will be added to the 
lipid samples to enhance the resolution between the signal from DMPC and DHPC in the 
control bicelle sample.  It will be included in the DMPC / C8E5 solutions as well.  
Praseodymium (III) chloride has been used successfully to differentiate the signal from 
DMPC and DHPC in 31P-NMR (3).   
Dynamic light scattering experiments were also carried out at theoretical q values 
based on previous studies that were carried out on DMPC / DHPC lipid systems (4).  
The diffusion of small particles or lipid aggregates to their hydrodynamic radius can be 
determined using the Stokes-Einstein equation where D is the diffusion coefficient of the 
fluctuating particles, k is the Boltzmann constant, T is the absolute temperature (K) and 
is held constant, η is the measured viscosity (cP), and the hydrodynamic radius, Rh (nm) 
is then calculated (5): 
   6 
The goal of the light scattering experiments was to determine if the morphology and size 
of the C8E5 / DMPC aggregates changed relative to the theoretical q value or the ratio 
of C8E5 to DMPC.  Last, the total lipid concentration was varied in order to determine if 
the lipid aggregate size and morphology vary depending on the total lipid concentration, 
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a characteristic that has been seen in DMPC / DHPC bicelle systems at different lipid 
concentrations (4).   
 The DMPC / C8E5 lipid solutions were evaluated in the analytical ultracentrifuge 
using sedimentation equilibrium to determine if these aggregates sediment in the 
absence of a density modifier.  Three different theoretical bicelle q values were 
evaluated: 0.1, 0.25, and 0.5 where q was determined by the moles of DMPC / moles of 
C8E5.       
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MATERIALS AND METHODS 
31P-phosphorus NMR Experiments 
 Samples with a 25% (w/w) total lipid composition, and q = 1.0 were prepared for 
31P-phosphorus NMR experiments.  To a 1.5 mL Eppendorf tube, 129.59 mg DMPC was 
added.  The DMPC powder was reconstituted into bicelles to a final volume of 1.0 mL 
with 254.30 µL of 25% (w/w) DHPC () or 101.25 µL of C8E5 (143mM), D2O, H2O, 3 M 
sodium acetate (pH 5.6) with a final composition of 10% (v/v) D2O, 90% H2O, and 20 
mM sodium acetate.  Praeseodymium chloride powder was added to a final 
concentration of 197 mM as per Glover et al. (4).  This concentration was previously 
determined to saturate the lanthanide-phospholipid interaction (3).   
 NMR experiments were carried out on a Bruker DRX500 spectrometer equipped 
with a BBI probe.  One dimensional 31P spectra were recorded at 25, 27, 29, 31, 35, 37 
°C using a proton-decoupled single-pulse experiment  with a minimum of 16 scans and a 
100 ppm sweep width.  The experiments were processed in TopSpin v. 1.3 (Bruker 
Corp.).     
 
Dynamic Light Scattering Experiments 
  C8E5 / DMPC lipid / detergent samples were prepared at different q values and 
different lipid concentrations.  In the first set of samples, the lipid concentration was held 
constant at 5% (w/w) while q varied from 0.05 to 0.5.  Samples were prepared on a 12 
mL volume scale: 
 102 
 
 In the second set of samples, the lipid concentration was varied between 1% and 
25% (w/w).  q was held constant at 0.25.  Samples were prepared on a 12 mL volume 
scale: 
 
    Viscosity measurements were carried out on a Cannon Fenske viscometer and 
light scattering experiments were carried out on an ALV-CGS3 compact goniometer 
q
5% lipid sample 40 X HEPES buffer
(0.4 M HEPES; 4 M 
NaCl pH 7.4)
ddH2O
DMPC (mg) C8E5 (µL)
0.05 52.91 552.62 300 µL 11.100 mL
0.10 97.24 507.83 300 µL 11.100 mL
0.15 134.93 469.77 300 µL 11.100 mL
0.20 167.36 437.01 300 µL 11.100 mL
0.25 195.57 408.52 300 µL 11.100 mL
0.30 220.32 383.52 300 µL 11.100 mL
0.35 242.21 361.40 300 µL 11.100 mL
0.40 261.72 341.69 300 µL 11.100 mL
0.45 279.21 324.03 300 µL 11.100 mL
0.50 294.99 308.10 300 µL 11.100 mL
% lipid 
concentration (w/w)
DMPC 
(mg)
C8E5 
(µL)
40 X HEPES buffer
(0.4 M HEPES; 4 M 
NaCl pH 7.4)
ddH2O
1 39.11 81.70 300 µL 11.580 mL
5 195.57 408.52 300 µL 11.100 mL
10 391.13 817.04 300 µL 10.500 mL
15 586.70 1225.55 300 µL 9.900 mL
20 782.27 1634.07 300 µL 9.300 mL
25 977.84 2042.59 300 µL 8.700 mL
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equipped with a 22 mW HeNe laser at a wavelength of 632.8 nm.  The autocorrelation 
function of scattered light intensity was acquired at 90 °C.  The intensity weighted 
hydrodynamic radius was determined for each DMPC / C8E5 lipid solution using the 
Cumulants algorithm provided by the ALV software.  
Sedimentation Equilibrium (AUC) 
 Three DMPC / C8E5 lipid solutions were evaluated at three theoretical q values: 
0.1, 0.25, and 0.5 and a total lipid composition of 5 % (w/w).  A small amount of NBD-
labeled DMPE was incorporated into DMPC / C8E5 samples to allow the lipid 
aggregates to be monitored using absorption optics.  The ratio of NBD-labeled lipid to 
unlabeled lipid was kept sufficiently high so that the label did not influence the physical 
properties of the aggregates (1:500 mole ratio of NBD-DMPE:DMPC).  Samples were 
prepared by lyophilizing appropriate amounts of DMPC and DMPE-NBD together.  The 
final sample volume was 150 µL: 
q value DMPC (mg) NBD-DMPE (mg) C8E5 (mg) ddH2O (µL) 40X HEPES 
buffer (µL) 
0.1 1.216 0.003650 6.35 138.75 4.0 
0.25 2.436 0.003650 5.11 138.75 4.0 
0.5 3.686 0.003650 3.85 138.75 4.0 
    
 All sedimentation equilibrium studies were carried out at 25 °C using a 6-channel 
equilibrium charcoal-filled epon centerpiece with a pathlength of 1.2 cm.  Samples were 
initially equilibrated at 10,000 rpm for 16 hours to allow equilibrium to be reached.  
Equilibrium measurements were evaluated using Match in the program, HeteroAnalysis 
(University of Connecticut, Storrs CT).  Thereafter speeds were increased by 5,000 rpm 
and samples were left to equilibrate for 4 hours before acquiring data.  A flat line with a 
zero slope indicates no sedimentation has occurred and Meff = 0 for the lipid aggregates.   
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RESULTS AND DISCUSSION 
 
31P-phosphorus NMR experiments reveal that the chemical shift of DMPC in 
bicelle and DMPC / C8E5 lipid solutions is very similar (Figures 5-1 and 5-2).  
Experiments were run at several temperatures to determine if the slight change in the 
DMPC chemical shift was enhanced with temperature.  Although, the chemical shift 
appears to fluctuate slightly in both solutions with changes in temperature, we would 
expect DMPC to have a significantly different chemical shift if it were not associated with 
C8E5 in a bicelle-like environment.  The peak for DMPC in C8E5 is shifted slightly 
downfield which is not completely surprising given the presence of oxygen atoms in the 
hydrocarbon tail of the C8E5 detergent whereas there are no oxygen atoms present in 
the hydrocarbon tail of DHPC.  The chemical shift data indicates that DMPC may be in a 
bicelle-like arrangement similar to what was previously observed by Glover et al (4).  
This study supports the hypothesis that DMPC / C8E5 associates in a bicelle-like 
manner.  To further characterize these lipid aggregates, dynamic light scattering 
experiments were carried out to measure the hydrodynamic radius as a function of 
theoretical q, moles of DMPC / moles of C8E5.  
 Results of the dynamic light scattering experiments reveal that as the theoretical 
q value of the C8E5 bicelles increases the hydrodynamic radius of the lipid aggregates 
increases significantly (Figure 5-3).  A lipid aggregate that contains a planar region, as in 
the case of bicelles, could carve out a large radius as it tumbles in solution giving rise to 
a sharp increase in the hydrodynamic radius as q gets larger.  A mixed micelle solution 
would not be expected to give rise to such a large increase in the hydrodynamic radius 
as q increases.  In general, the DMPC / C8E5 lipid aggregates are much larger 
compared to DMPC / DHPC bicelles (4).  In Figure 5-4 the affect of the total lipid 
concentration (% w/w) on the hydrodynamic radius of the aggregates was plotted.  As 
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the lipid concentration increases, the hydrodynamic radius of the aggregates 
approaches zero.  Data at a lipid concentration of 25% (w/w) could not be collected, 
which may be attributed to the apparent decrease in size with increasing lipid 
concentration.  The size of the lipid aggregates decreases with increasing lipid 
concentration even when q is held constant at 0.25. 
 Figure 5-5 shows the results of the sedimentation equilibrium experiment.  
Experiments show that DMPC / C8E5 lipid aggregates are not as dense as traditional 
DMPC / DHPC bicelles, but they still migrate down the solution column at modest 
speeds indicating that they have a density that is significantly higher than water.  Without 
the use of a density modifier, it is not possible to completely density match the DMPC / 
C8E5 lipid-detergent aggregates.   
  
 106 
CONCLUSIONS 
 The goal of this study was to find an alternative bicelle-like lipid aggregate that 
would provide a bilayer environment in which to characterize protein oligomerization.  
Ideally, the new bilayered lipid aggregate would have a density that was equal to the 
density of water so that density matching sedimentation equilibrium experiments would 
not have to be carried out.  By avoiding the need to add a density modifier such as D2O, 
excessive speeds can be avoided in sedimentation equilibrium experiments so that 
smaller proteins can be evaluated for their oligomeric activity.  Although the data suggest 
that DMPC / C8E5 aggregates form a bicelle-like arrangement similar to traditional 
DMPC / DHPC bicelles, preliminary density matching experiments show that these lipid 
aggregates are slightly more dense than water and require the need for density 
matching much like DMPC / DHPC bicelles.   
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q value, 5% lipid 
(w/w)
Dynamic Viscosity
(Pa * s)
Viscosity
(cP)
0.05 0.00128 1.27659
0.10 0.00130 1.29977
0.15 0.00129 1.29047
0.20 0.00130 1.29959
0.25 0.00129 1.29459
0.30 0.00131 1.31296
0.35 0.00135 1.35020
0.40 0.00132 1.32339
0.45 0.00150 1.50336
0.50 0.00151 1.51056
Table 5.1  Viscosity measurements of DMPC / C8E5 samples at 
various theoretical q values.  
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q = 0.25,
% lipid (w/w)
Dynamic 
Viscosity
(Pa*s)
Viscosity
(cP)
Rh
(nm)
1 0.00109 1.09144 8.69
5 0.00129 1.28765 4.84
10 0.00182 1.82314 2.22
15 0.00286 2.85859 1.33
20 0.00441 4.41406 0.82
25 0.00674 6.73514 N/A
Table 5.2  Viscosity measurements of DMPC / C8E5 samples at 
various lipid concentrations. 
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Figure 5-1.  Overlay of 1-D 31P-phosphorus NMR spectra of DMPC / DHPC 
bicelles with DMPC / C8E5 lipid aggregates at 25 °C .  The chemical shift of 
DMPC is highly similar in both lipid samples.
 
DMPC from  
C8E5 sample 
DMPC from  
DHPC sample 
DHPC 
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Red = DMPC / DHPC bicelle sample
Blue = DMPC / C8E5 sample
20 mM acetate, pH 5.6, 197 mM Pr3+ at 37 °C
Figure 5-2.  Overlay of 1-D 31P-phosphorus NMR spectra of DMPC / DHPC 
bicelles with DMPC / C8E5 lipid aggregates at 37 °C .  The chemical shift of 
DMPC is highly similar in both lipid samples.
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Figure 5-3.  Hydrodynamic radius, Rh, versus theoretical q 
values of DMPC / C8E5 solutions.   
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Figure 5-4.  Hydrodynamic radius, Rh, versus % 
lipid concentration (w/w) of DMPC / C8E5 
solutions. 
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Figure 5-5.  Preliminary sedimentation equilibrium (SE) data of DMPC / 
C8E5 lipid aggregates doped with NBD-labeled DMPE to allow aggregates 
to be monitored at 464 nm.  Sector 1 of the SE centerpiece contains q = 
0.1 lipid aggregates, sector 2 contains q = 0.25 lipid aggregates, and 
sector 3 contains q =0.5 lipid aggregates.  Each panel shows the results 
acquired at different speeds: A) 10,000 rpm B) 15,000 rpm C) 20,000 rpm 
D) 25,000 rpm E) 30,000 rpm F) 35,000 rpm.   
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Chapter 6. Expression and Purification of Membrane Proteins 
ABSTRACT 
Expression of membrane proteins in bacteria has proven to be a very useful tool 
in which to acquire useful quantities of membrane protein for biophysical studies. 
Membrane proteins are extremely toxic to the organisms from which they are expressed 
and achieving high yields is cumbersome.  Ideal expression conditions vary from protein 
to protein and often expression methods must be determined empirically.  In these 
studies, E. coli was used to express different proteins ranging from small peptides (2 kD) 
up to fully active proteins with native enzymatic activity (23 kD).  To mitigate the toxic 
effects of membrane protein expression to the E. coli host, most of the proteins were 
expressed as fusions to a Trp Leader peptide sequence.  Trp Leader (tryptophan 
operon) is native to E. coli and expresses very readily compared to non-native 
mammalian proteins.  This sequence also directs protein expression into inclusion 
bodies which protects the host organism from the toxic effects of membrane protein 
expression.  Ultimately by expressing proteins into inclusion bodies, large quantities can 
be achieved.  In the following chapter, the Trp Leader expression system proved 
successful at expressing the desired constructs.  Further, E. coli was able to express a 
full-length protein as well; however, it was not able to produce enzymatically active 
protein.       
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INTRODUCTION  
 In the field of membrane protein biophysics new methodologies are continuously 
explored to facilitate and enhance the study of these proteins.  To assess the utility of 
new biochemical and biophysical methods it is often advantageous to employ model 
peptides whose properties have been well-characterized in order to assess the value of 
a new method.  One peptide that is commonly used is a synthetic peptide called 
“WALP”.  The WALP peptide is comprised of leucine and alanine repeats flanked on 
both ends by either tryptophan (W) or lysine (K) residues which help to anchor the 
peptide in lipid bilayers (1, 2, 3).  The WALP peptide can vary in length from 16 up to 31 
residues long and can be tailored to the needs of the experiment in which it will be used.  
WALP was chosen as a model peptide in order to evaluate the utility of bicelles in the 
analytical ultracentrifuge.  The goal was to express and purify the WALP peptide from E. 
coli so that it can be reconstituted into bicelles and its molecular weight calculated from 
sedimentation equilibrium experiments in the AUC.  WALP is known to be monomeric; 
therefore, this peptide is a suitable model for which the bicelle system can be evaluated 
before investigating proteins whose oligomeric nature is unknown.  Although micelles 
have been successfully used to study membrane protein oligomerization, discretion must 
be used when interpreting the data because micelles have properties that are different 
from the lipid bilayer where membrane proteins reside.  For example, the extreme 
curvature of micelles has the potential to influence the tertiary structure of proteins which 
can affect oligomerization.  Another membrane protein that was expressed and purified 
for the purposes of evaluating bicelles in the AUC was the E. coli outer membrane 
protein (OmpX).  OmpX has been well characterized structurally and functionally and 
has been shown to be readily incorporated into lipid bilayers (4, 5, 6, 7, 8, 9).  OmpX 
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also has a higher molecular weight which is expected to allow for adequate 
sedimentation in bicelles under density matched conditions (71.7% D2O). 
 Other sections of this chapter describe, in detail, the expression and purification 
of caveolin-1(62-178) (referred to as Cav1(62-178)) constructs including wild type and 
the many mutants that were used for the oligomerization studies executed in Chapter 2.  
The details of the expression and purification of WALP and the caveolin constructs are 
presented together in this chapter because their preparation follows the same 
procedure.        
The last section of this chapter describes the expression and purification of a 
membrane associating protein called phosphatidylethanolamine methyltransferase A 
(PmtA).  PmtA is responsible for transferring a methyl group from an S-
adenosylmethionine to the plasma membrane lipid, phosphatidylethanolamine (PE).  
This process occurs three times in order to convert phosphtidylethanolamine to 
phosphatidylcholine (PC) in the bacterial species, R. sphaeroides.  PmtA was expressed 
and purified from E. coli in order to study the nature of its interaction with the lipid bilayer 
(10).    
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MATERIALS AND METHODS 
WALP, Cav1(62-178), and Cav1 Mutants (P132L, Truncated and Point Mutants) 
Preparation of WALP Gene  
 The WALP peptide sequence that was chosen for this study was based on a 
study carried out by Whiles et al., NH2-MAKKLLLALLLALLLLALLLWKK-COOH (11).  
A tryptophan residue was included at the C-terminus of the construct to allow for an 
appreciable absorbance at 280 nm which will facilitate monitoring of the peptide during 
the purification process and in downstream studies.  A methionine residue was also 
included so the peptide may be cleaved from its fusion partner after expression and 
purification using cyanogen bromide.   
Primers for the full-length WALP sequence were ordered from Invitrogen Life 
Technologies (Grand Island, NY) and both primers included BamH1 and EcoR1 
restriction sites for cloning:  
5’-CGCGG ATCCA TGGCG AAAAA ACTGC TGCTG CGCGC TGCTG CTGGC GCTGC 
TGCTG CTGGC GCTGC TGCTG TGGAA AAAAT GAGAA TTCCG G-3’ 
3’- CCGGA ATTCT CATTT TTTCC ACAGC AGCAG CGCCA GCAGC AGCAG CGCCA 
GCAGC AGCGC CAGCA GCAGT TTTTT CGCCA TGGATC CGCG-5’  
The gene was amplified using PCR.  All reagents used for PCR except the primers were 
purchased from New England Biolabs (Ipswich, MA) unless otherwise specified.  The 
reaction was set up on a 50 µL scale with reagents added in the following order to a 
sterile thin-walled PCR tube: 
 
Sterile dH2O         41.1 µL 
10X ThermoPol buffer       5.0 µL 
dNTPs (25 mM each)        0.4 µL 
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5’ WALP primer (2 µg / µL)       1.0 µL 
3’ WALP primer (2 µg / µL)       1.0 µL 
Taq Polymerase        1.0 µL  
 
PCR Cycling Conditions: 
1 cycle  X  94 ⁰C      2 minutes 
5 cycles X  94 ⁰C      15 seconds 
    40 ⁰C      15 seconds 
    72 ⁰C      1.0 minute 
1 cycle  X  72 ⁰C      5.0 minutes 
Storage   4 ⁰C      ∞ 
 
After optimization of the PCR reaction, the presence of the PCR product was 
confirmed using a 1.5 % agarose gel.  The agarose gel was prepared by dissolving 1.5 
grams of agarose (EMD Millipore, Billerica, MA) in 100 mL 1 X Tris-acetate-EDTA, pH 
8.0 buffer (Appendix I).  The TAE buffer was prepared (Appendix I).  The gel was cast 
into a horizontal mini-gel system from C.B.S. Scientific (Del Mar, CA).  To 4 µL of the 
PCR product 1 µL of 5 X nucleic acid sample loading buffer (Biorad, Hercules, CA) was 
added.  2-log DNA ladder (NEB, Ipswich, MA) was run in parallel on the agarose gel at 
140 Volts for 50 minutes using the Biorad PowerPac™ HC Power Supply for 
electrophoresis.  The gel was stained in a 0.5 µg / mL ethidium bromide solution for 20 
minutes and destained in dH2O for 20 minutes.  The presence of a 100 base pair band 
was assessed using a UV transilluminator at a wavelength of 365 nm. 
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Preparation of Cav1(62-178) Gene 
The gene for caveolin-1(62-178) (referred to as Cav1(62-178)) was synthesized 
with BamH1 and EcoR1 restriction sites by Genscript (Piscataway, NJ).  A methionine 
residue was incorporated at the beginning of the construct to allow chemical cleavage of 
Cav1(62-178) from its fusion partner in downstream studies (Figure 6-1).  The 
synthesized gene was supplied in a pUC19 vector and was transformed into XL1-Blue 
cells, and a glycerol stock was prepared (Appendix I).   
 
Ligation of WALP and Caveolin-1(62-178) 
 The WALP PCR product and Cav1(62-178) genes were ligated into a pET-
TrpLE-Ubiquitin-24a or pET-nTrpLE-24a E. coli expression vector, respectively.  These 
vectors were a gift from the E. Komives Lab at the University of California, San Diego 
(San Diego, CA).  The vectors contain a Trp-Leader protein sequence which codes for 
the partial sequence of a native E.coli protein.  The “n” in the pET-nTrpLE-24a vector 
represents a codon-optimized version of the original TrpLE sequence from the Komives 
Lab.  Proteins that are expressed as fusions to the Trp-Leader sequence are often 
directed into inclusion bodies.  Also, it is possible to obtain high-level protein expression 
using this vector.  The WALP PCR product was gel purified on a 1.5% agarose gel and 
the 100 base pair band was excised from the gel and purified using the Qiagen Gel 
Extraction Kit (Valencia, CA).  A 5 mL LB culture of E. coli containing the pET-TrpLE-
Ubiquitin-24a or pET-nTrpLE-24a vector was grown overnight at 37 ⁰C and pelleted 
using a benchtop microcentrifuge.  The pET-TrpLE-Ubiquitin-24a or nTrpLE vectoral 
DNA was extracted from E. coli cells and purified using the Qiagen Miniprep kit 
(Valencia, CA).  The WALP PCR product, Cav1(62-178), pET-TrpLE-Ubiquitin-24a, pET-
nTrpLE-24a DNA were subjected to double digest with BamH1 and EcoR1 restriction 
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enzymes (New England Biolabs, Ipswich, MA).  The reactions were set up in separate 
sterile 1.5 mL Eppendorf tubes according to the conditions described below:  
 
DNA (WALP, Cav1(62-178), pET-TrpLE-Ubiquitin-24a, pET-nTrpLE-24a) 42.5 µL 
10X EcoR1 Buffer 5.0 µL 
100X BSA 0.5 µL 
BamH1 restriction enzyme 1.0 µL 
EcoR1 restriction enzyme 1.0 µL 
 
The reactions were left to proceed for at least 20 hours at room temperature.  The 
product of the digest reactions was purified using a 1.0% agarose gel (1.5% agarose gel 
for WALP).  The band corresponding to the expected DNA product size was excised 
from the gel and purified using the QIAquick Gel Extraction kit (Qiagen, Valencia, CA).  
The purified DNA was quantitated using a 1.0% agarose gel (1.5% for WALP).  After the 
DNA was quantitated, a ligation reaction was set up using 50 ng of vectoral DNA as the 
limiting reagent and a 200-fold excess of WALP or Cav1(62-178) insert was added to the 
reaction.  10X T4 ligase buffer was added to the reaction followed by 1.0 µL of T4 Ligase 
enzyme (New England Biolabs, Ipswich, MA).  A control was prepared in parallel to the 
ligation reaction with sterile dH2O used instead of the insert DNA.  The control and 
ligation reactions were allowed to proceed at room temperature for 16-20 hours.   
 The ligation and control reactions were transformed into either DH5α (Invitrogen 
Life Technologies, Grand Island, NY) or XL1-Blue subcloning grade competent cells 
purchased from Stratagene / Agilent (Santa Clara, CA) and test digests were performed 
(Appendix I).  To each of the reactions, 2.5 µL of 5X nucleic acid sample loading buffer 
was added and the samples were run on a 1.5% agarose gel for 50 minutes at 140 
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Volts.  The gel was stained in ethidium bromide and destained in dH2O and the presence 
of the insert, 100 base pairs, and the vector, 5000 base pairs, were assessed.  The 
correct DNA sequence from the picked colonies was confirmed by Jutta Marzillier, Ph.D 
in the Department of Biological Sciences (WALP) (Lehigh University, Bethlehem, PA) or 
Genewiz Corp.(Cav1(62-178)) (South Plainfield, NJ).  The DNA that was extracted from 
the DH5α or XL1-Blue colony was transformed into BL21-DE3 competent cells 
purchased from Invitrogen Life Technologies (Grand Island, NY) following the procedure 
in Appendix I.  0.20 µL of DNA was used to transform BL21-DE3 cells.  The SOC culture 
was plated on a MDAG agar plate containing kanamycin and incubated overnight at 37 
⁰C.  The following day 3-5 colonies were picked from the plate and grown in 5 mL of 
MDAG broth containing kanamycin.  Glycerol freezes were prepared for each of the 
colonies. 
 
Preparation of Caveolin-1 P132L, Truncated and Point Mutant Genes 
 Mutagenesis primers were designed using the PrimerX web program (Carlo 
Lapid and Yimin Gao; hosted by Bioinformatics.org) and the original nucleotide 
sequence for Cav1(62-178).  The desired mutations were introduced into the primers 
and PCR was carried out using Cav1(62-178) as the template DNA: 
 
Site-directed Mutagenesis PCR Reaction: 
Sterile ddH2O         15.3 µL 
10X Pfu AD buffer        2.5 µL 
10X 9° N Ligase buffer       2.5 µL 
DMSO          0.2 µL 
dNTPs (100 mM)        1.0 µL  
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template DNA (10 ng / µL)       0.5 µL  
FOR 5’ quikchange primer (125 ng / µL)     1.0 µL   
Pfu Turbo polymerase       1.0 µL 
9° N Ligase         1.0 µL 
 
PCR Cycling Conditions: 
1 cycle  x  95 °C      30 seconds 
30  x  95 °C      30 seconds 
  x  55 °C      1 minute 
  x  68 °C      6 minutes 
Storage x  4 °C      ∞ 
 
To the PCR reaction was added 1 µL of Dpn I endonuclease to digest the methylated 
parental DNA strand.  The Dpn I reaction was left to proceed overnight at 37 °C.  1 µL of 
the Dpn I reaction was used to transform a 50 µL aliquot of XL1-Blue subcloning grade 
E. coli cells (Appendix I).  Colonies were picked from the LB agar plates and grown in 5 
mL of LB-KAN broth for 12-16 hours.  The cells were pelleted and DNA extracted using 
the QIAprep Miniprep Kit (Qiagen, Valencia, CA).  The DNA was sequenced to confirm 
the presence of the desired mutation (Genewiz, South Plainfield, NJ).   
 
Expression and Purification of WALP, Caveolin-1(62-178), and Caveolin-1 P132L, 
Truncated and Point Mutants 
Each of the picked BL21-DE3 colonies was tested for the expression of the 
WALP, Cav1(62-178), or Cav1(62-178) mutants (Appendix I).  The growths from which 
the glycerol freezes were made were propagated by adding 50 µL of the culture to 5 mL 
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of fresh MDAG media containing kanamycin.  The growths were incubated at 37 ⁰C with 
shaking at 225 rpm for 3 hours.  After 3 hours, 100 µL of the culture was transferred to a 
1.5 mL eppendorf tube and 100 µL of 2X SDS sample loading buffer (Laemmlli buffer) 
was added.  The samples were heated in boiling water and vortexed.  To the remainder 
of the growths 0.95 µL of 1 M isopropyl β-D-1-thiogalactopyranoside (IPTG) was added 
to induce the expression of the nTrpLE-WALP fusion protein.  The growths were allowed 
to proceed for another 3 hours at 37 ⁰C with shaking.  Afterwards, 100 µL of the growths 
were transferred to a 1.5 mL eppendorf tube and 100 µL of 2X SDS buffer was added.  
The samples were boiled in a water bath and the “non-induced” and “induced samples” 
were loaded onto an SDS-PAGE gel: 5 %T stacking gel, 15 % T resolving gel and run in 
standard electrophoresis buffer at 150 V for 1 hour and 20 minutes.  The ColorPlus pre-
stained protein ladder (10-230 kDa) (NEB, Ipswich, MA) was included in lane 1 to 
evaluate the molecular weight of the protein bands.  The gel was stained for 30 minutes 
in Coomassie Brilliant Blue R-250 and destained for several hours until the bands could 
be visualized.  The presence of the fusion protein on the gel was assessed and the 
intensity of the stained band determined which colony best expressed the desired 
protein.   
 Once the best expressing colony was determined, a large scale growth was 
performed using a 6-liter shaker flask using the auto-induction method for high-density 
cultures (12).  First, a starter culture was prepared by adding 5 mL of MDAG media 
(Appendix II) to a 10 mL culture tube followed by the addition of 5 µL of 30 mg / mL 
kanamycin to the media.  The media was inoculated using the BL21-DE3 WALP / 
Cav1(62-178) glycerol stock by poking the freeze with a micropipette tip to obtain an ice 
chip.  The tip was ejected into the 10 mL culture and incubated at 37 ⁰C overnight 
(minimum 16 hours) with shaking at 225-250 rpm.  The following day, 2 mL of the starter 
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growth was added to 2 liters of pre-warmed ZYM-5052 sterile media (Appendix II).  The 
2-liter growth was incubated at 37 ⁰C with shaking at 225-250 rpm.  Progress of the 
growth was monitored by measuring the OD600nm of the culture every hour and plotting 
the growth profile of the protein.  Once the density of the growth leveled off, the cells 
were harvested in 1-liter aliquots by centrifugation at 5,000 x g at 4 ⁰C for 30 minutes.  
The supernatant was discarded and each cell pellet was washed by re-suspending the 
cell pellets in 80 mL of ice-cold 0.9% NaCl solution.  The cells were spun again at 5,000 
x g for 30 minutes at 4 ⁰C.  The supernatant was discarded from the second spin and the 
remaining cell pellets could be stored at -80 ⁰C for several months.   
 A series of selective wash steps was performed to purify the protein from the 
harvested cell pellets.  The desired protein was expressed in highly insoluble inclusion 
bodies, which facilitates the partial purification of the desired protein using several wash 
steps that are designed to remove unwanted proteins.  To a 1-liter cell pellet, 
approximately 200 mL of 20 mM Tris buffer pH 8.0 containing 20% sucrose (w/v) was 
added.  The cell pellet and buffer were sonicated in a 600-mL beaker with stirring using 
a Branson sonifier with a flat tip head.  Cells were ruptured using a 40% duty cycle, 
power level 9 with stirring.  The sonication proceeded for 15 minutes in the cold room.  
The homogenized mixture was centrifuged in a JA-14 tube using a Beckman floor model 
preparative ultracentrifuge.  The contents of the tube were spun at 27,500 x g for 2 hours 
at 8 ⁰C.  The pellet was retained and the supernatant was discarded.  A second wash 
step was performed to remove broken pieces of cell membrane and membrane bound 
proteins.  The pellet was resuspended in 200 mL of 20 mM Tris pH 8.0 buffer containing 
1% Triton X-100 (v/v) in a 600-mL beaker.  The mixture was sonicated again with stirring 
at a 40% duty cycle, power level 9 for 15 minutes in the cold room.  The homogenized 
mixture was centrifuged again in a JA-14 tube at 27,500 x g for 45 minutes at 8 ⁰C.  The 
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supernatant was discarded and the pellet was retained and subjected to a second wash 
with the 1% Triton X-100 buffer.  The supernatant was discarded and the pellet was 
subjected to one last wash step with 200 mL of 20 mM Tris buffer pH 8.0 containing 60% 
isopropyl alcohol (v/v) which was designed to remove traces of Triton X-100.  The 
sonication and centrifugation steps were repeated from the Triton X-100 wash step.  The 
supernatant was discarded and the grayish white pellet was retained and dried under a 
stream of nitrogen gas to remove traces of isopropyl alcohol.  A sample of the pre-spun 
mixture was retained at all steps along with a sample of the supernatant when each spin 
was complete.  The fusion protein was tracked through all wash steps to track the target 
protein.  The pellet was dissolved in 40 mL of 88% formic acid and centrifuged in a JA-
20 tube for 30 minutes at 21 ⁰C.  The supernatant was retained and subjected to 
cyanogen bromide in order to cleave the fusion protein and liberate the desired peptide.  
To the formic acid mixture, 0.2 g of cyanogen bromide crystalline powder was added.  
The solution was bubbled under a stream of nitrogen gas for 5 minutes.  The reaction 
was covered with aluminum foil and allowed to rotate overnight for a minimum of 18 
hours at room temperature (Figure 6-2).  The reaction mixture was dried down in a 
Savant speed vacuum concentrator to remove the formic acid and cyanogen bromide.  
The dried film was re-dissolved in 88% formic acid to final concentration of 
approximately 5 mg / mL.  The TrpLE-Ubiquitin or nTrpLE protein was separated from 
WALP or Cav1(62-178) and mutants, respectively, using a Phenomenex (Torrance, CA) 
Jupiter C4 reverse-phase HPLC column with a 15 µm particle size with a 300 Å pore 
size.  A gradient elution was performed using a mobile phase consisting of 20% acetic 
acid / 80% dH2O and changing over to 20% acetic acid / 80% butanol at a rate of 2.5% 
per minute.  The identity of the peak is confirmed using MALDI-TOF mass spectrometry. 
The desired protein is collected and dried to a thin film using the speed vacuum 
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concentrator.  The protein film is dissolved in HFIP to which dH2O is added to a final 
concentration of 70% (v/v).  Immediately after adding the dH2O the solution is frozen in 
liquid nitrogen and lyophilized.  The lyophilized protein is stored at -20 ⁰C and is stable 
for several months. 
 
OmpX 
 A pET-28a vector containing the OmpX gene was generously provided by the 
Berger Lab (Lehigh University, Bethlehem, PA).  The DNA sequence of OmpX was 
verified (GENEWIZ, South Plainfield, NJ) and contained an N-terminal hexahistidine tag 
to facilitate purification.  The DNA was transformed to XL1-Blue cells and plated on LB 
agar containing kanamycin.  The plate was incubated overnight at 37 °C and three to 
five colonies were picked the following day.  The picked colonies were grown in 5 mL of 
LB broth containing kanamycin overnight at 37 °C sh aking at 225-250 rpm on a platform 
shaker (New Brunswick Scientific, Edison, NJ).  Glycerol freezes were prepared from 
each of the 5 mL cultures (Appendix I) and the remaining culture was pelleted.  DNA 
from the XL1-Blue cells was extracted and purified using the QIAprep Miniprep Kit 
(Qiagen, Valencia, CA) and transformed into chemically competent E. coli BL21-DE3 
cells purchased from Invitrogen Life Technologies (Grand Island, NY) (Appendix I).  The 
SOC culture was plated on an MDAG agar plate containing kanamycin and incubated 
overnight at 37 ⁰C.  The following day 3-5 colonies were picked from the plate and grown 
in 5 mL of MDAG broth containing kanamycin.  Glycerol freezes were prepared for each 
of the colonies (Appendix I).   
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Expression and Purification of OmpX from E. coli 
 To 5 mL of sterile MDAG-KAN, a chip of the OmpX glycerol freeze was added.  
The MDAG starter culture was incubated at 37 °C ove rnight (12-16 hours) with shaking 
at 250 rpm on a platform shaker (New Brunswick Scientific, Edison, NJ).  The following 
morning 5 mL of MDAG starter culture was added to 2 liters of ZYM-5052 media.  The 
growth was left to proceed at 37 °C with shaking at  220-250 rpm for 9 - 10 hours.  The 
cells were harvested by centrifugation at 5000 x g for 30 minutes at 4 °C in two 1-liter 
centrifuge bottles.  Each one-liter cell pellet was resuspended in 130 mL of ice cold 0.9% 
NaCl (w/v) solution and centrifuged at 5000 x g for 30 minutes at 4 °C.  The supernatant 
was poured off and the one-liter pellets were stored at 80 °C. 
A one-liter cell pellet was suspended in 240 mL of 50 mM phosphate buffer pH 7 
containing 8 M urea.  The cells were lysed by sonication using a Branson Sonifier at a 
40% duty cycle, power level 9 while stirring for 15 minutes.  Afterward, the lysate was 
spun at 27,500 x g for 2 hours at 8 °C.  The cleare d lysate was incubated with 
approximately 10 mL of Nickel-NTA resin (Qiagen, Valencia, CA) to bind hexahistidine-
labeled OmpX to bind to the resin.  The resin was washed with three column volumes 
(30 mL) of 50 mM phosphate buffer pH 7 containing 8 M urea and 20 mM imidazole.  
The column was batched eluted with 20 mL of 50 mM phosphate buffer pH 7 containing 
8 M urea and 250 mM imidazole.        
 
Phosphatidylethanolamine methyltransferase (PmtA) 
 Genomic DNA from R. sphaeroides was purchased from American Type Culture 
Collection (ATCC, Manassas, VA).  Primers to the PmtA gene were designed and 
purchased from Invitrogen (Carlsbad, CA): 
5’ –GGTAT TCCAT ATGGA ACTTG ACGCG GTAAG CCGGA G – 3’ 
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3’ – CCGGA ATTCT CAGCG GCGCT GGAAG CGCAG GAAGG TGA – 5’ 
The gene was amplified using PCR.  All reagents used for PCR except the primers were 
purchased from New England Biolabs (Ipswich, MA) unless otherwise specified.  The 
reaction was set up on a 50 µL scale with reagents added in the following order to a 
sterile thin-walled PCR tube: 
 
Genomic DNA from R. sphaeroides (100 ng / µL)   1.0 µL 
FOR 5’ primer (200 ng / µL)      2.0 µL 
REV 3’ primer (200 ng / µL)      2.0 µL 
5 x Optimization Kit Buffer E      10.0 µL 
PCR water from kit       29.8 µL 
Taq Polymerase (5000 U / mL)     0.2 µL 
dNTPs (2.5 mM each from kit)     5.0 µL   
    
Cycling Conditions: 
 1 cycle    X  94 °C   2 minutes 
30 cycles   X  94 °C   15 seconds 
    X  55 °C   15 seconds 
    X  72 °C   45 seconds 
1 cycle    X  72 °C   5 minutes 
Storage     4 °C   ∞ 
 
The PCR product was verified on a 1% agarose gel (631 base pairs) and purified 
using the PCR Quick Cleanup from the QIAquick Gel Extraction Kit (Qiagen, Valencia, 
CA). A 5 mL LB culture of E. coli containing the pET-24a vector was grown overnight at 
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37 ⁰C and pelleted using a benchtop microcentrifuge.  The pET-24a vectoral DNA was 
extracted from E. coli cells and purified using the Qiagen Miniprep kit (Valencia, CA).    
The purified PmtA and pET-24a DNA was double digested in separate sterile 1.5 mL  
Eppendorf tubes: 
 
DNA (PmtA insert or pET-24a)     43.0 µL 
10 X EcoR1 buffer       5.0 µL 
EcoR1 Endonuclease       1.0 µL 
Nde1 Endonuclease         1.0 µL 
 
Reactions were left to proceed for 20 hours at room temperature (overnight).  
The products of the double digest reactions were purified and quantitated on a 1.0% 
agarose DNA gel.  After the DNA was quantitated, a ligation reaction was set up using 
50 ng of vectoral DNA as the limiting reagent and a 200-fold excess of PmtA insert was 
added to the reaction.  10X T4 ligase buffer was added to the reaction followed by 1.0 µL 
of T4 Ligase enzyme (New England Biolabs, Ipswich, MA).  A control was prepared in 
parallel to the ligation reaction with sterile dH2O used instead of the insert DNA.  The 
control and ligation reactions were allowed to proceed at room temperature for 16-20 
hours.   
 The ligation and control reactions were transformed into DH5α subcloning grade 
E. coli cells (Invitrogen Life Technologies, Grand Island, NY) and test digests were 
performed (Appendix I).  To each of the reactions, 2.5 µL of 5X nucleic acid sample 
loading buffer was added and the samples were run on a 1.0% agarose gel for 50 
minutes at 140 Volts.  The gel was stained in ethidium bromide and destained in dH2O 
and the presence of the insert, 631 base pairs, and the vector, 5000 base pairs, were 
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assessed. The correct DNA sequence from the picked colonies was confirmed by Jutta 
Marzillier, Ph.D in the Department of Biological Sciences (Lehigh University, Bethlehem, 
PA).  The DNA extracted from the DH5α E. coli cells was transformed into BL21-DE3 
competent cells purchased from Invitrogen Life Technologies (Grand Island, NY) 
following the procedure in Appendix I.  0.20 µL of DNA was used to transform BL21-DE3 
cells.  The SOC culture was plated on a MDAG agar plate containing kanamycin and 
incubated overnight at 37 ⁰C.  The following day 3-5 colonies were picked from the plate 
and grown in 5 mL of MDAG broth containing kanamycin.  Glycerol freezes were 
prepared for each of the colonies. 
 
Expression and Purification of PmtA in E. coli 
Each of the picked BL21-DE3 colonies was tested for the expression of PmtA 
(Appendix I).  The growths from which the glycerol freezes were made were propagated 
by adding 50 µL of the culture to 5 mL of fresh MDAG media containing kanamycin.  The 
growths were incubated at 37 ⁰C with shaking at 225 rpm for 3 hours.  After 3 hours, 100 
µL of the culture was transferred to a 1.5 mL eppendorf tube and 100 µL of 2X SDS 
sample loading buffer (Laemmlli buffer).  The samples were heated in boiling water and 
vortexed.  To the remainder of the growths 0.95 µL of 1 M isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to induce the expression of PmtA protein.  The 
growths were allowed to proceed for another 3 hours at 37 ⁰C with shaking.  Afterwards, 
100 µL of the growths were transferred to a 1.5 mL eppendorf tube and 100 µL of 2X 
SDS buffer was added.  The samples were boiled in a water bath and the “non-induced” 
and “induced samples” were loaded onto an SDS-PAGE gel: 5 %T stacking gel, 15 % T 
resolving gel and run in standard electrophoresis buffer at 150 V for 1 hour and 20 
minutes.  The ColorPlusTM pre-stained protein ladder (10-230 kDa) (NEB, Ipswich, MA) 
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was included in lane 1 to evaluate the molecular weight of the protein bands.  The gel 
was stained for 30 minutes in Coomassie Brilliant Blue R-250 and destained for several 
hours until the bands could be visualized.  The presence of the fusion protein on the gel 
was assessed and the intensity of the stained band determined which colony best 
expressed the desired protein.   
 Once the best expressing colony was determined, a large scale growth was 
performed using a 6-liter shaker flask using the auto-induction method for high-density 
cultures (12).  First, a starter culture was prepared by adding 5 mL of MDAG media to a 
10 mL culture tube followed by the addition of 5 µL of 30 mg / mL kanamycin to the 
media.  The media was inoculated using the BL21-DE3 WALP / Cav1(62-178) glycerol 
stock by poking the freeze with a micropipette tip to obtain an ice chip.  The tip was 
ejected into the 10 mL culture and incubated at 37 ⁰C overnight (minimum 16 hours) with 
shaking at 225-250 rpm.  The following day, 2 mL of the starter growth was added to 2 
liters of pre-warmed ZYM-5052 sterile media.  The 2-liter growth was incubated at 37 ⁰C 
with shaking at 225-250 rpm.  Progress of the growth was monitored by measuring the 
OD600nm of the culture every hour and plotting the growth profile of the protein.  Once the 
density of the growth leveled off, the cells were harvested in 250-500 mL aliquots by 
centrifugation at 5,000 x g at 4 ⁰C for 30 minutes.  The supernatant was discarded and 
each cell pellet was washed by re-suspending the cell pellets in 80 mL of ice-cold 0.9% 
NaCl solution.  The cells were spun again at 5,000 x g for 30 minutes at 4 ⁰C.  The 
supernatant was discarded from the second spin and the remaining cell pellets could be 
stored at -80 ⁰C for several months. 
 A 500 mL pellet was reconstituted into ice-cold 40-50 mL of 50 mM phosphate 
pH 8, 10 mM Imidazole, 300 mM NaCl buffer.  The E. coli cells were lysed by sonication 
using a microtip sonifier on duty cycle 10%, power level 3.  The material was kept on ice 
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and temperature did not exceed 16 °C.  The lysate w as further purified by centrifuging at 
4 °C for 30 minutes.  The cleared lysate was filter ed through a 0.2 µm syringe filter and 
applied to 1 mL of Ni-NTA resin in a 4 °C cold room .  The column was washed with two 
column volumes (10 mL) of 50 mM phosphate pH 8, 20 mM Imidazole, 300 mM NaCl 
(ice cold) and eluted in 1 mL fractions with 50 mM phosphate pH 8, 250 mM Imidazole, 
300 mM NaCl.  Fractions were evaluated in SDS-PAGE for the presence of PmtA, 
pooled and exchanged into 50 mM phosphate pH 8, 150 mM NaCl buffer.  The purified 
PmtA was stored at 4 °C.     
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RESULTS AND DISCUSSION 
WALP 
 The goal of cloning, expressing and purifying the WALP peptide was to use this 
peptide as a model that could be incorporated into bicelles and its oligomeric state 
evaluated in the analytical ultracentrifuge.  WALP is known to be a monomer; therefore, 
its oligomeric state could be determined with confidence using density matched bicelles 
in the analytical ultracentrifuge.  Initially, WALP was cloned into a pET-TrpLE-Ubiquitin-
24a vector and expressed as a tandem fusion to TrpLE-Ubiquitin.  TrpLE is known to 
promote protein expression into inclusion bodies, which is often desirable when 
expressing highly toxic membrane proteins.  The TrpLE system has been used 
successfully to express large quantities of membrane proteins.  WALP was found to be 
best expressed in a tandem fusion to both TrpLE and Ubiquitin.  Figure 6-3 shows the 
results of the test expression performed on this construct.  We can see from SDS-PAGE 
that a 25 kD band appears after protein production was initiated by the addition of IPTG.  
This band corresponds to the molecular weight of the TrpLE-Ubiquitin-WALP fusion.  
Next, a large-scale growth of TrpLE-Ubiquitin-WALP was performed to produce sufficient 
quantities of WALP for downstream studies.  An inclusion body preparation was 
performed on the cells harvested from this large-scale growth.  Next, the semi-pure 
inclusion bodies were dissolved in 88% formic acid and a cyanogen bromide reaction 
was carried out to chemically cleave TrpLE-Ubiquitin from WALP (Figure 6-2).  The 
reaction was purified by reverse phase HPLC and fractions were collected.  Figure 6-4 
shows the results of HPLC.  WALP is extremely hydrophobic compared to TrpLE-
Ubiquitin and was expected to elute last from the HPLC column.  The identity of the 
starred peak was confirmed to be WALP using MALDI-TOF mass spectrometry (Figure 
6-5).  The results of the MALDI-TOF analysis show that the cleavage product has a 
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monoisotopic molecular weight of 2.473 kDa, which coincides with the predicted 
molecular weight of the gene product that was created for this protein.  Once the 
molecular weight of the cyanogen bromide cleavage product was confirmed, the 
lyophilized material could be used for analytical ultracentrifugation studies. 
 The purpose of this study was to express a small model peptide, WALP, which 
could be used to assess the utility of bicelles as a system to study membrane proteins in 
the analytical ultracentrifuge.  The WALP peptide was successfully cloned, expressed 
and purified using the E. coli bacterial expression system.  The TrpLE–Ubiquitin tandem 
fusion system gave the highest peptide yield.  The Ubiquitin fusion system yielded 
truncated expression products with little to no detectable full-length protein, which was 
confirmed by western blot analysis.  The TrpLE system did not yield appreciable 
amounts of the WALP peptide.  Based on these results, it was concluded that the E. coli 
expression system is most effective at expressing larger proteins having a molecular 
weight close to approximately 25 kDa.  Small peptides are best expressed as fusions 
yielding a final protein molecular weight close to 25 kDa.  The WALP peptide was later 
incorporated into bicelles, however, under the density matched conditions of bicelles, it 
was found that the WALP peptide, with a calculated partial specific volume of 0.847 cm3 
/ g, failed to sediment in the analytical ultracentrifuge under density matched conditions 
preventing a meaningful concentration profile from being achieved.  Bicelles are 
relatively large, dense lipid aggregates and they require a D2O concentration of 
approximately 75% (v/v) to be matched.  While unsuitable for small, hydrophobic 
peptides, bicelles may be better suited to the analysis of larger membrane proteins. 
 It is clear from previous efforts to characterize the WALP peptide using bicelles in 
the analytical ultracentrifuge that the size of the peptide can pose problems in density 
matched systems.  This is especially true in the case of DMPC / DHPC bicelles where 
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high amounts of D2O must be used to match the bicelles (72.4% D2O).  Using small 
peptides in this system requires that extremely high speeds be achieved to generate 
sufficient curvature in the concentration profile of the peptide and this can cause leaking 
of the equilibrium centerpieces.  To circumvent this problem, the use of a larger 
membrane protein will be explored.  Outer membrane protein X (OmpX) is an integral 
membrane protein that is situated in the outer membrane of E. coli.  It is a highly 
conserved bacterial membrane protein that belongs to a large family of outer membrane 
proteins and they are thought to enhance bacterial resistance to mammalian cells.  Both 
the NMR and crystal structure of OmpX have been solved and it forms an eight strand β-
barrel, which creates a pore that has been implicated in adhesion and mammalian cell 
invasion.  OmpX has a molecular weight of 17.5 kDa, which is much higher than that of 
WALP, 2.47 kDa.  Like WALP, OmpX is also monomeric in the lipid bilayer of the plasma 
membrane.  This membrane protein may serve as a better candidate to evaluate the 
utility of bicelles in the analytical ultracentrifuge, since extreme speeds should not be 
required to sediment this protein under density matched conditions. 
 
OmpX 
 OmpX was successfully expressed and isolated from E. coli cells using the 
inclusion body method previously established in the Kerney Jebrell Glover Lab (13).  A 
small sample of prepared material was retained at each step of the inclusion body 
preparation in order to track the protein during this process.  Figure 6-6 shows the 
results of the inclusion body prep.  A strong 17.5 kD molecular weight band is observed 
in the pre-spun material for both the sucrose and Triton X-100 wash steps.  OmpX is 
very hydrophobic and is expected to be relatively insoluble, traveling with the 
hydrophobic inclusion body-enriched material in the pre-spin samples.  Lane 2 and 4 are 
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the pre-spun washes and we can see that a 17.5 kD band is present.  In the supernatant 
from these washes (Lanes 3 and 5) the 17.5 kD band is no longer visible, indicating that 
this material is present in the inclusion bodies.  Once the semi-pure inclusion bodies 
were obtained, OmpX was further purified on a Ni-NTA affinity chromatography column.  
The column was eluted and fractions were collected and run on an SDS-PAGE gel to 
confirm the presence of a 17.5 kD band.  Figure 6-7 shows that there is a large quantity 
of material that elutes from the column at approximately 17.5 kD, which is evidence for 
the presence of OmpX.  The OmpX enriched fractions were pooled and stored for bicelle 
reconstitution studies. 
 
Cav1(62-178) and Cav1(62-178) Mutants 
 Cav1(62-178) and Cav1(62-178) mutants were expressed and purified using a 
similar approach to the TrpLE-Ubiquitin-WALP method.  The constructs were 
overexpressed in E. coli and grown in ZYM-5052 media for approximately 9-10 hours or 
until the growth profile leveled off (Figure 6-8).  After the cells were harvested, an 
inclusion body preparation was carried out to partially purify the overexpressed Cav1(62-
178)_WT and Cav1(62-178) mutant constructs.  After dissolving the inclusion bodies in 
88 % formic acid, a cyanogen bromide reaction was carried out to liberate Cav1(62-
178)_WT and Cav1(62-178) mutants from the Trp Leader protein.  The cleavage 
products were separated using HPLC.  Figure 6-10 shows representative trace from the 
HPLC purification of the Cav1(62-178) constructs.  Because Cav1(62-178)_WT and the 
Cav1(62-178) mutants are highly hydrophobic, they are always the last to elute from the 
column.  The red star above the peak in the HPLC trace notes Cav1(62-178)_WT.  The 
identity of Cav1(62-178) along with the identity of the Cav1(62-178) mutants was 
confirmed by MALDI-TOF mass spectrometry (Figure 6-11).   
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PmtA 
 PmtA was transformed into E. coli BL21-DE3 cells and successfully expressed 
based on the results of the test expression (Figure 6-12).  An inclusion body preparation 
reveals that PmtA expressed in inclusion bodies (Figure 6-13a).  Ni-NTA affinity 
chromatography was carried out to purify PmtA (Figure 6-13b), and later gel filtration to 
remove all unwanted proteins.  The purity of the final PmtA material was assessed by 
SDS-PAGE (Figure 6-14) and was shown to be pure.  The enzyme was assayed for 
activity, but showed no level of activity.  Other attempts to express PmtA at lower 
temperatures and in minimal media resulted in no appreciable enzyme activity.  
Although, PmtA was successfully expressed and purified, this method failed to produce 
active enzyme for downstream studies. 
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CONCLUSIONS 
 The expression methods presented in this chapter have proven useful in 
producing extremely hydrophobic proteins, which are otherwise toxic to bacterial host 
cells.  Large quantities were achieved, however, using the inclusion body approach to 
express and purify small peptides and membrane proteins.  E. coli is also useful for 
expressing higher level full-length proteins albeit without enzymatic activity.  To produce 
enzymatically active protein the use of a higher level organism such as yeast may be 
necessary.  Another approach could be to express full-length protein in E. coli and 
attempt to refold it in vitro.     
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M Desired ConstructTrp Leader Ubiquitin
Figure 6-1. Schematic diagram of pET-24a plasmid and the 
construct design of WALP, Cav1(62-178)_WT and Cav1(62-
178) mutants.  A methionine residue was incorporated before 
the desired protein sequence so that chemical cleavage could 
be carried out to separate the fusion.   
 Figure 6-
proposed by Inglis and Edman (1970) 
37 73-80 (14).
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2.  Mechanism of cyanogen bromide reaction 
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Figure 6-3.  SDS-PAGE gel of TrpLE-Ubiquitin-WALP 
test expression.  The appearance of a band can be seen 
when IPTG was added to the culture to induce 
expression.  The newly visible band corresponds to the 
MW of TrpLE-Ubiquitin-WALP.   
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Figure 6-4.  HPLC separation of cleavage products from 
CNBr reaction of TrpLE-Ubiquitin-WALP.  
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Figure 6-5.  MALDI-TOF mass spectrometry of purified 
WALP peptide.  The spectrum was obtained using a 
Bruker MicroflexTM in positive reflectron mode for 0-5 kD 
peptides.    
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Figure 6-6.  SDS-PAGE gel of inclusion body prep. for 
OmpX.    
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Figure 6-7.  SDS-PAGE gel of Ni-NTA affinity column 
purification of OmpX 
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Figure 6-8.  Growth profile of E. coli in auto-induction 
media.  After the OD levels off, cells are harvested. 
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Figure 6-9.  SDS-PAGE gel test expression of two Cav1(62-
178) truncated mutants: Cav1(96-178) and Cav1(82-136).  The 
red box highlights the appearance of a band corresponding to 
the expected molecular weight of the gene product upon 
induction with IPTG.  Two colonies are show per construct.  
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Figure 6-10.  HPLC separation of cleavage products from CNBr reaction of 
nTrpLE-Cav1(62-178) and select Cav1(62-178) mutants.  The red starred peaks 
represent Cav1(62-178) WT and mutants.  
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Figure 6-11.  MALDI-TOF mass spectrometry of purified 
Cav1(62-178) peptide.  The spectrum was obtained using 
a Bruker MicroflexTM in positive reflectron mode for 5-20 kD 
peptides.    
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Figure 6-12.  SDS-PAGE gel of PmtA test expression.  
The appearance of a band can be seen when IPTG was 
added to the culture to induce expression.  The newly 
visible band corresponds to the MW of PmtA.   
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175 kD
30 kD
17 kD
80 kD
23 kD
46 kD
175 kD
30 kD
17 kD
PmtA
MW = 22.5 kD
1 = ColorPlusTM Protein Ladder 
2 = 20 mM Tris pH 8 / 20% Sucrose wash; pre spin
3 = 20 mM Tris pH 8 / 20% Sucrose wash; post wash 
4 = 20 mM Tris pH 8 / 1% Triton X-100 wash; pre spin
5 = 20 mM Tris pH8 / 1% Triton X-100 wash; post spin
6 = 20 mM Tris pH 8 / 1% Triton X-100 wash; pre spin
7 = 20 mM Tris pH 8 / 1% Triton X-100 wash; post spin
8 = 20 mM Tris pH 8 / 8 M urea; pre spin
9 = 20 mM Tris pH 8 / 8 M urea; post spin
2 3 4 5 6 7 8 91 2 3 4 5 6 7 8 91
1 = BLANK
2 = BLANK
3 = BLANK
4 = Column Flow Through: 50 mM phosphate, 8 M Urea pH8
5 = Wash:  50 mM phosphate, 8 M Urea, 20 mM Imidazole pH8
6 = Elution:  50 mM phosphate, 8 M Urea, 250 mM Imidazole pH8 
7 = BLANK
8 = BLANK
9 = BLANK
a. b.
Figure 6-13.  a) SDS-PAGE gel of PmtA inclusion body prep.  A prominent 22.5 
kD band can be tracked through the wash steps of the prep.  Columns 8 and 9 
show that PmtA is soluble when 8 M urea is present in the buffer. b) A Ni-NTA 
column was carried out after the inclusion body prep to further purify PmtA.  Some 
of the protein was lost in the unbound fraction, lane 4, and in the wash step, lane 
5.  Lane 6 shows the eluted protein.    
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17 kD
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MW = 22.5 kD
Figure 6-14.  SDS-PAGE evaluation of PmtA purity.  A single 
22.5 kD band can be seen from the gel.  Traces of 
contaminating proteins are too low to be detected by SDS-
PAGE, which implies that the protein is highly pure and ready 
for downstream studies. 
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Appendix I. Common Lab Procedures and Protocols 
 
Preparing and Running a DNA Agarose Gel  
 
1. Prepare a 1.0% agarose gel by dissolving 1 gram of agarose (EMD Millipore, 
Billerica, MA) in 100 mL of 1X TAE buffer.  Carefully boil the mixture to dissolve 
the agarose. 
 
2. Cast the gel in a horizontal mini-gel system (C.B.S. Scientific, Del Mar, CA). 
 
3. Fill the DNA gel box with 1X TAE buffer until the gel is completely submerged.  
 
4. Load the DNA in the appropriate lanes.  Do not exceed 12.5 µL of DNA per well. 
 
5.  5 µL of 2-Log DNA ladder (NEB, Ipswich, MA) is included on the DNA gel for 
assessment of DNA size. 
 
6. Once the DNA has been loaded on the gel, place the lid securely on the mini-gel 
box electrodes. 
 
7. Run the gel at 140 Volts for 50 minutes using the BioRad PowerPac™ HC Power 
Supply (BioRad, Hercules, CA). 
 
8. The gel is stained for 20 minutes using 0.5 µg / mL Ethidium bromide in 1X TAE 
buffer and destained for 20 minutes in dH2O. 
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Purification of Digested DNA using Qiagen Gel Extraction kit (Valencia, CA) 
 
1. To a 50 µL digest reaction add 12.5 µL of 5X Nucleic Acid sample loading buffer. 
 
2. Load the sample across five lanes on an agarose DNA gel and run gel (see 
above). 
 
 
3. Using a clean razor blade excise the correct DNA band from the gel taking care 
to eliminate excess agarose. 
 
4. Transfer the excised band to a pre-weighed 15-mL centrifuge tube (VWR 
International). 
 
5. Weigh the excised DNA.  Add 3X the volume of QG buffer that is equivalent to 
the grams of weighed material.  Ex. To 300 mg of agarose, add 900 µL of QG 
buffer (Qiagen Kit) 
 
6. Place the centrifuge containing DNA and QG buffer in a 50 ºC water bath and 
vortex every few minutes until the agarose is completely dissolved (approx. 10 
minutes). 
 
7. Add another equivalent of isopropanol.  Ex. 300 mg of agarose, add 300 µL of 
isopropanol  
 
8. Vortex and add the mixture to a Qiagen spin column (max. capacity is 750 µL).  
Spin the column at 17,900 x g for 30 seconds and discard the material in the 
collection tube. Repeat until all of the mixture has been added and spun in the 
column. 
 
9. Remove traces of agarose by adding 500 µL of QG buffer to the spin column. 
Spin at 17,900 x g for 30 seconds.  Discard contents of collection tube. 
 
10. Wash the DNA by adding 750 µL of Buffer PE (Qiagen kit) to the spin column 
and centrifuge at 17,900 x g for 30 seconds.  Discard contents of collection tube. 
 
11. Spin column again for 1 minute to remove all traces of ethanol from the Buffer 
PE. 
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12. Place the spin column in a sterile 1.5 mL Eppendorf tube (Axygen, Corning, NY).  
Add 1:10 buffer EB (Qiagen kit) directly to the column membrane and incubate 
for one minute. 
 
13. Spin the column at 17,900 x g for 1 minute to elute the DNA from the spin 
column. 
 
Transformation into Competent E. coli Cells 
 
This procedure is adapted from Molecular Cloning Techniques; Volume 3, Cold Spring 
Harbor  
(All steps to be carried out using sterile technique) 
 
1. Remove a 50 µL aliquot of frozen chemically competent cells from the -80 ºC 
freezer and thaw on wet ice. 
 
2. Chill a 10-mL sterile culture tube on wet ice for several minutes. 
 
3. Transfer the contents of the 50 µL aliquot to the chilled culture tube. 
 
4. Add 1-50 ng of DNA to the chemically competent cells and gently tap the tube to 
mix the DNA and cells. 
 
5. Replace the culture on ice immediately and incubate for 30 minutes. 
 
6. After 30 minutes heat shock the cells in the culture tube for 90 seconds in a 42 
ºC water bath. 
 
7. Replace the culture tube on ice for 2 minutes. 
 
8. Add 450 µL of SOC broth to the culture tube and incubate at 37 ºC with shaking 
at 22-250 rpm for one hour. 
 
9. Pre-warm a LB agar plate containing the appropriate selective marker at 37 ºC 
until cells are finished incubating. 
 
10. Spread 450 µL of cells onto the pre-warmed LB agar plate containing the 
appropriate selective marker using a sterile spreader. 
 
11. Allow 5-15 minutes for the broth to soak into the agar and incubate the plate 
upside down overnight (16-20 hours) at 37 ºC in the dark. 
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Note: For BL21-DE3 cells a 1:50000 dilution of the SOC broth into sterile LB broth is 
plated to avoid overgrowth of the plate. 
 
 
 
 
Preparation of E. coli Glycerol Stocks for Growths 
 
1. To a sterile cryotube (VWR International) 250 µL of sterile 60% (v/v) glycerol was 
added. 
 
2. 750 µL of a bacterial culture is added to the crytoube and immediately vortexed 
for 1 second with the lid on. 
 
3. The cryotube is then immersed in a beaker of liquid nitrogen for 3 minutes and 
stored at -80 ºC. 
 
Procedure for DNA Test Digest 
 
1. Pick a single colony from an LB agar plate.  Grow in 5 mL of LB broth containing 
the desired antibiotic for 12-16 hours at 37 °C wit h shaking at 225-250 rpm. 
 
2. Pellet all of the culture by spinning the material in a 2.0 mL Eppendorf tube and 
aspirating the supernatant.   
 
3. Using the QIAprep Miniprep Kit (Qiagen, Valencia, CA) extract and purify the 
DNA from the pelleted cells. 
 
4. To a sterile 1.5 mL Eppendorf tube add 10 µL of the purified, miniprepped DNA. 
 
5. Add 1 µL of 10X restriction enzyme buffer (New England Biolabs, Ipswich, MA) to 
the DNA. 
 
6. Add a small volume of restriction enzyme to the DNA: 
 
BamH1 0.25 µL Add 1.0 µL 10X BSA  
EcoR1  0.25 µL 
NdeI  0.5 µL 
 
7. Incubate the reaction at 37 °C for 30 minutes. 
 
8. Analyze the test digest reaction on a 1.0% agarose gel for the presence of the 
gene product and the vector DNA (approx. 5000 bp). 
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Procedure for Protein Test Expression 
 
1. Pick a single bacterial colony from an MDAG or LB plate and grow in 5 mL of 
MDAG or LB broth containing antibiotic overnight at 37 ºC. 
 
2. Transfer 50 µL of the overnight culture to 1 mL of fresh MDAG or LB broth 
containing antibiotic and incubate with shaking at 220-250 rpm for three hours at 
37 ºC in the dark. 
 
3. After three hours remove 100 µL of the culture and immediately add 100 µL of 2 
X SDS buffer.  Boil the sample and vortex vigorously to kill cells. 
 
4. To the remaining culture (900 µL) add 1 M IPTG to a final concentration of 1 mM 
(0.90 µL).  Incubate the culture with shaking at 220-250 rpm for three hours at 37 
ºC.  
 
5. After three hours remove 100 µL of the cell culture and add 100 µL of 2X SDS 
buffer to the cells.  Immediately boil and vortex vigorously to kill cells.    
 
6. Run an SDS-PAGE gel of the sample loading the non-induced sample and 
induced samples side-by-side to compare.      
 
Note: For protein test expression MDAG is often used since it does not contain any 
traces of lactose.  Some batches of LB may contain traces of lactose which can 
prematurely induce protein expression. 
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Preparation of SDS-PAGE Gels 
 
1. Using the Mini-Protean Gel Casting Stand (BioRad, Hercules, CA), set up two gel 
casting plate assemblies in the stand.  
 
2. Prepare gel solutions based on the table below.  For proteins ≤ 30 kDa a 15% T 
gel was used.  For proteins 30 kDa-50 kDa a 12% T gel was used.  For proteins 
≥ 50 kDa a 10% T gel was used: 
 
 
 
Gel Solutions 
 
Stacking gel, 
7.5% T 
Running gel, 
10% T 
Running gel, 
12% T 
Running gel, 
15% T 
19:1 Bis acrylamide 
solution 675 µL  5.63 µL 6.75 µL 
Acrylamide running 
buffer  4.5 µL 4.5 µL 4.5 µL 
10% SDS solution 67 µL 180 µL 180 µL 180 µL 
Water 4.1 mL    
TEMED 3 µL 6 µL 6 µL 6 µL 
10% APS solution     
*The APS solution is added immediately before pouring the acrylamide solutions. 
 
3. The acrylamide running gel is distributed evenly into each of the two gel casts 
leaving 2 mL of solution behind in the tube.  A layer of water is added to the top 
of the poured acrylamide in each cast. 
 
4. After the acrylamide has polymerized, the water is poured off and the acrylamide 
stacking gel is poured on top of the polymerized running gel distributing evenly 
across both casts.  2 mL of stacking acrylamide gel is left behind in the tube.  A 
gel comb is added immediately to the top of the cast containing acrylamide 
stacking gel solution.  
 
5. The gel is polymerized by assessing the small amount of acrylamide solution left 
behind in the tube.   
 
6. The prepared gel is assembled in a BioRad Mini-PROTEAN gel box.  1X 
electrophoresis buffer is added to the gel box. 
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7. SDS-PAGE samples are prepared by adding 5X SDS reducing sample buffer to 
the protein sample.  The sample is boiled in a water bath to denature the protein. 
 
8. Samples are carefully loaded at the top of the SDS-PAGE gel (20-40 µL).  A 
ColorPlus™ pre-stained protein marker (NEB, Ipswich, MA), range 7-175 kDa,  is 
included in the first lane.     
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Appendix II.  Buffers, Growth Media, Solutions 
 
 
5X Nucleic Acid Loading Buffer 
 
50 mM Tris-HCl, pH 8.0 
25% Glycerol 
5 mM EDTA 
0.2% Bromophenol Blue 
0.2% Xylene Cyanole FF 
 
 
50X Tris-Acetate EDTA (TAE) Buffer 
 
242 g of Tris base 
57.1 mL of glacial acetic acid 
100 mL of 0.5 M EDTA (pH 8.0) 
 
 
1X Western Blot Transfer Buffer 
 
57.6 g glycine 
12.1 g Tris base 
800 mL methanol 
Final volume = 4 liters 
 
 
 
10X TBS Buffer 
 
24.2 g Tris base 
292.4 g NaCl 
Adjust pH to 7.5 
Final volume = 1 liter 
 
 
1X TBST Buffer 
 
Dilute 10X TBS and add 500 µL Tween-20 per 1 liter 
 
 
5X SDS Loading Buffer (Reducing) 
 
20% (v/v) glycerol 
100 mM Tris pH 6.8 
200 mM β-mercaptoethanol 
4% SDS (w/v) 
0.2% bromophenol blue (from a 5% stock solution) 
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10X Electrophoresis Buffer 
 
144 grams glycine 
30 grams Tris base 
5 g SDS 
Final volume = 1 liter 
*diluted to 1X when running an SDS-PAGE gel 
 
 
Acrylamide Gel Buffer 
  
1.5 M Tris adjusted to pH 8.8 
 
 
Acrylamide Stacking Gel Buffer 
 
0.5 M Tris adjusted to pH 6.8 
 
 
Coomassie Blue Staining Solution / Destaining Solution 
 
5 g Coomassie blue R-250  
1000 mL of Methanol 
200 mL of Acetic acid 
800 mL of dH2O 
*omit the Coomassie blue for the destaining solution 
 
 
ZYM-5052 Growth Media (Auto-Induction Media)  
*Studier, F. W. (2005) Protein Production by Auto-Induction in High Density Shaking Cultures. 
Protein Expr. Purif. 41, 207-234. 
 
For a 2-liter growth: 
 
20 g NZ-Amine AS  
10 g yeast extract 
1916 mL ddH2O 
Autoclave on Fluid cycle for 20 minutes 
Allow media to cool to room temperature 
Add 4 mL of sterile 1 M MgSO4 (sterile) 
Add 400 µL 1000 X Trace Metals (sterile) 
Add 40 mL of 50 X M (salts) (sterile) 
Add 40 mL of 50 X 5052 (glucose and lactose) (sterile) 
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N-5052 Auto-Induction Growth Media (For 15N-labeled growths) 
*Studier, F. W. (2005) Protein Production by Auto-Induction in High Density Shaking Cultures. 
Protein Expr. Purif. 41, 207-234. 
 
For a 2- liter growth: 
 
14.196 g Na2HPO4 
13.609 g KH2PO4 
1.42 g Na2SO4 
5.45 g 15NH4Cl 
Autoclave on Fluid cycle for 20 minutes 
Allow media to cool to room temperature 
4 mL MgSO4 (sterile) 
400 µL 1000 X Trace Metals (sterile) 
40 mL 50 X 5052 (glucose and lactose) (sterile) 
 
 
MDG (MDAG) Starter Culture Growth Media 
*Studier, F. W. (2005) Protein Production by Auto-Induction in High Density Shaking Cultures. 
Protein Expr. Purif. 41, 207-234. 
 
For a 5 mL growth: 
* All solutions are pre-sterilized) 
 
4.6 mL ddH2O (4.46 mL for MDAG) 
10 µL 1 M MgSO4 
1 µL 1000 X Trace Metals 
50 µL 50 X M 
62.5 µL 40% Glucose 
 
For MDAG, add amino acids 
100 µL 17 amino acids  
40 µL methionine  
 
5 µL 1000 X antibiotic (typically kanamycin)  
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